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iAbstract
The study of the brain using diffuse optical methods has progressed rapidly
in the recent years. The possibility of studying the cerebral microvasculature in
addition to the portability and low cost of these devices, opens a new door in
the study of the cerebral pathophysiologies.
In this scenario, the study of the cerebral hemodynamics of ischemic pa-
tients might allow neurologists to improve the performance of the early medical
treatments and therapies used up to date. In this thesis, I have conducted a
pioneering study where cerebral autoregulation was studied in ischemic stroke
patients during the early hours after the stroke.
Similarly, some other diseases can provoke impaired cerebral autoregulation
in the long term. One of them is the obstructive sleep apnoea (OSA) syndrome
which can provoke a risk increase of developing cardiovascular diseases and
ischemic stroke. In this regards, I have carried out the largest to date study
conducted with Diffuse Correlation Spectroscopy in patients with OSA and I
have compared their hemodynamical response to an orthostatic challenge test
with a control group of healthy subjects.
Finally, primary animal research is of great importance in the development
of new therapies, medical strategies and in the validation of new drugs with
the aim of reducing the high mortality and slow and costly recovery of ischemic
patients. In consequence, many models of ischemia are reproduced in rodents
where the cerebral hemodynamics are studied using expensive equipments such as
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MRI scanners or by techniques that involve invasive approaches like for instance
removing the scalp or thinning the skull which in turn cause a worsening in the
living conditions of the animal.
In relation to this point, I have developed a fully non-invasive method to
study the cerebral hemodynamics in rats that allows to proceed with longitudinal
studies and which I hope will be useful in future biomedical research.
iii
Resumen
El estudio del cerebro mediante me´todos de o´ptica difusa ha progresado
ra´pidamente en los u´ltimos an˜os. La posibilidad de estudiar la microvasculatura
cerebral junto con la portabilidad y bajo coste de estos equipos abren una ventana
de posibilidades para el estudio de fisiopatolog´ıas cerebrales. En este escenario,
el estudio de la hemodina´mica cerebral en pacientes isque´micos podr´ıa permitir
a los neuro´logos mejorar el rendimiento de los tratamientos me´dicos tempranos
y de las terapias utilizadas hasta la fecha. En esta tesis he realizado un estudio
pionero al respecto, estudiando por primera vez la hemodina´mica cerebral de
pacientes isque´micos durante las primeras horas despue´s del infarto cerebral.
De igual manera, existen otro tipo de enfermedades que pueden desarrollar
un empeoramiento a largo plazo de la autorregulacio´n cerebral. Entre ellas
destaca el s´ındrome de apnea obstructivo (SAO), debido al cual el empeoramiento
de la hemodina´mica cerebral provoca un aumento del riesgo directo de sufrir
enfermedades cardiovasculares y un aumento del riesgo de infarto cerebral. Al
respecto, he llevado a cabo el mayor estudio hasta la fecha con pacientes con
SAO donde he estudiado su respuesta hemodina´mica a un test ortosta´tico y
comparado estos resultados con los obtenidos en grupo de control de pacientes
sanos.
Finalmente, la investigacio´n primaria en animales es de vital importancia en
el desarrollo de nuevas terapias y estrategias me´dicas as´ı como en la validacio´n de
nuevos fa´rmacos que reduzcan la alta mortalidad y la lenta y costosa recuperacio´n
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de los pacientes isque´micos. En consecuencia, numerosos modelos de isquemia son
reproducidos en roedores donde se estudia la hemodina´mica cerebral mediante
caros equipos como los resonadores magne´ticos o mediante te´cnicas que implican
someter al animal a cierta cirug´ıa en la que se le sustrae el cuero cabelludo o
se le lima el cra´neo. En relacio´n con esto u´ltimo, he desarrollado un me´todo
completamente no invasivo para estudiar la hemodina´mica cerebral en ratas y
que permite llevar a cabo estudios longitudinales, el cual espero sea utilidad en
futuras investigaciones biome´dicas.
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Thesis Objectives
Near-infrared diffuse correlation spectroscopy (DCS) is a non-invasive tech-
nique that allows to study the brain hemodynamics in human and animals in
many clinical and medical scenarios.
Hypotheses
• Evoked functional activation in rats can be measured using a fully non-
invasive longitudinal approach with diffuse correlation spectroscopy.
• The blood flow response to orthostatic challenge measured in ischemic
stroke patients during the early hours after stroke is correlated to clinical
outcome parameters such as the National Institutes of Health Stroke Scale
or the modified Rankin Scale.
• Obstructive Sleep Apnoea patients classified in different groups according
to the number of apnoeas/hypopnoeas per hour during sleep will show
different cerebral blood flow responses to an orthostatic stress test.
Objectives xx
Objectives
• To explore the feasibility of a fully non-invasive longitudinal diffuse corre-
lation spectroscopy method using a particular anesthesia protocol to study
the evoked functional activation in rats.
• To study the hemodynamics of ischemic stroke patients during the early
hours after stroke using a portable diffuse correlation spectroscopy device.
• To study the hemodynamics of Obstructive Sleep Apnoea patients and
to explore if groups of patients classified according to the number of ap-
noeas/hypopnoeas per hour during sleep show different cerebral blood flow
responses to an orthostatic stress test and to find out if the cerebrovascular
reactivity may correlate with key respiratory parameters.
1
Introduction
The understanding of brain function and its pathologies is one of the major
challenges of medicine in 21st century. The impact of stroke in the society [1,2],
associated to growing ageing population in the West has provoked an increase
of the public interest about the brain and the study of the processes involved on
its functions. In this regards, clinical applications such as bedside brain function
monitoring are expected to play a key role in a near future as portable fast
diagnosis tools by means of reducing brain damage. This allows scenarios where
the emergency squads start medical actions at the origin, prior to take the patient
to the hospital with its consequent reduction in economical and social costs.
The brain is a complex organ that needs a regular supply of oxygen and
nutrients through blood flow to guarantee its normal function. The study of the
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mechanisms involved on this delivery are of great interest in the neuroscience
community where cerebral microvasculature takes center stage. The cerebral
autoregulation (CA), first described by Roy and Sherrington in 1890 [3], is the
mechanism responsible of providing regular cerebral blood flow (CBF) when
there is a change in the cerebral perfusion pressure (CPP) [4]. This process is
controlled by the cerebrovascular reactivity (CVR) which regulates the diameter
of the blood vessels in response to the increased CPP as illustrated on Figure 1.1.
60 100 160 40 80 120 140 
CPP (mm Hg) 
C
B
F 
Vascular Reactivity 
CA Diagram 
Figure 1.1: Diagram of cerebral autoregulation [5]: The cerebrovascular reactivity
(CVR) is the mechanism that alters the diameter of the blood vessels in order
to keep a constant cerebral blood flow (CBF) when there is an increase in the
cerebral perfusion pressure (CPP)
There is a relation between impaired CA and certain neurological, cardiac
and respiratory diseases [6–13] . In consequence, monitoring the neurovascularity
of patients with impaired CA can be of great use for physiologists in terms of
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studying the reasons that cause its unnormal functioning. This might open the
gate to develop early detection tools and to explore ad-hoc treatments which, in
both cases, might reduced the impact of the above mentioned diseases. Due to
this reasons, many technologies were used to study the cerebral hemodynamics
-hence CA- by means of monitoring the cerebral blood flow (CBF), the cerebral
blood flow velocity (CBFV) or the tissue oxygenation.
Thereby, transcraneal doppler (TCD) [14,15] is an extended clinical tool that
monitors CBFV but can only be used in large blood vessels [16] and its use is
restricted to the thinner walls -insonation windows- of the skull [17].
CBF can be monitored at microvascular level through magnetic resonance
imaging (MRI) [18] or computed tomography (CT) based techniques, such as ar-
terial spin labeled perfusion magnetic resonance imaging (ASL-MRI) [19], Xenon-
enhanced computed tomography (XeCT) [20] or positron emission tomography
(PET) [21]. Unfortunately, these techniques involve expensive equipments with
poor mobility and some of them use radioactive tracers.
Blood oxygen level dependent (BOLD) functional magnetic resonance imag-
ing [22, 23] uses the presence of oxy- and deoxy-hemogloblin to study changes
in the vascular reactivity induced by neuronal activity in three dimensional to-
mographic brain maps with moderate spatial resolution. However, its signal is
difficult to interpret due to its low signal-to-noise ratio and complex statistical
methods used. Also, this technique present similar issues in terms of economical
costs and poor mobility.
Optical techniques are used to monitor cerebral hemodynamics by focusing on
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the absorption and scattering properties of tissue. For instance, optical intrinsic
signals imaging (OISI) [24–26] uses the reflectance of light to indicate active
portions of the cortex but this method is limited to superficial measurements.
Near-infrared spectroscopy (NIRS) is based on light at some particular wave-
lengths being absorbed by certain chromophores like oxy- and deoxy-hemoglobin.
As consequence, transcranial blood volume and blood oxygen saturation have
been estimated. On the other hand, light scattering experiments obtain dynamic
information of the medium by measuring the temporal fluctuations of the light
intensity at the detectors. Among these, laser Doppler flowmetry (LDF) [27,28]
and laser speckle flowmetry (LSF) [29] have provided relatively low-cost alter-
natives but, as before, these methods are limited to superficial measurements.
However, diffuse correlation spectroscopy (DCS) is a relatively low cost, portable
technique with high temporal resolution that allows blood flow measurements
in deep tissues [30–38].
1.1 Diffuse Optical Techniques
Jobsis [39] realized that in the near-infrared photons could travel deep into tissue
due to the reduced absorption coefficients of water and hemoglobins. Within
this ’physiological window’ (Figure 1.2) that ranges from 650-900nm, the light
transport is dominated by scattering rather than absorption and the photon
transport can be approximated as a diffusive process. Here, the light absorption
is caused by the presence of water, lipids, and particularly the oxy- and deoxy-
hemogloblin among some other chromophores.
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“Physiological Window” 
Figure 1.2: Absorption spectrum of tissue chromophores and location of the
”Physiological Window” where absorption is relatively low.
Based on three different types of sources, near-infrared spectroscopy can be
separated into continuous-wave (CW), frequency-domain (FD) and time-domain
(TD) modalities where FD and TD allow to separate absorption from scattering
process. On the other hand, diffuse correlation spectroscopy (DCS) allows non-
invasive measurements of the blood flow in deep tissues through the interaction
of the NIR light with the red blood cells and actually, this technology is able to
reach the human brain transcranially [34,35].
NIRS and DCS can be combined into an hybrid device which allows to
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measure the CBF, the total hemoglobin concentration and the blood oxygen
saturation.
1.2 Thesis Outline
I have centered this work on the study of the brain by means of developing
DCS applications in rat and human in vivo tissues with the aim of studying
the cerebral hemodynamics. This work has a clear medical orientation as it
covers different scenarios where the CVR might be impaired like in patients
with Obstructive Sleep Apnoea (OSA) syndrome to diseases where the CVR is
impaired such as ischemic stroke. This last case is also the motivation for the
study carried out with rats in this Thesis.
Accordingly, these challenges involved the utilization of both hybrid and
single DCS devices, the creation of new optical probes or engineering solutions
to avoid their displacement over long measurements among some other topics
that will be described in detail in the following chapters.
Chapter 2 provides with the theoretical background that allows to study
cerebral hemodynamics with diffuse correlation spectroscopy whereas Chapter
3 describes the instrumentation used by means of equipments, design of new
probes and engineering solutions to the bedside clinical applications developed.
Chapter 4 describes the design of a non-invasive surface optical probe and the
protocol used to study the rat brain hemodynamics by measuring the functional
activation in the somatosensory area provoked by a set of electrical stimuli. The
validation of this technique allows the neuroscience community to proceed with
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longitudinal studies using a portable cheap device. Furthermore, it permits the
researchers to study and to monitor the recovery of rat brain ischemia models
through the use of new pharmacological drugs or rich environment therapies.
Chapter 5 studies the hemodynamics of ischemic stroke (IS) patients during
the early hours after the stroke onset through an orthostatic stress challenge.
The mean values of the relative cerebral blood flow (rCBF) for each patient
at a given HOB angle and time stage are obtained and correlations of rCBF
with other demographic and clinical parameters (includying recombinant tissue
plasminogen activator (rtPA) treatments) are explored by using linear mixed
effects (LME) models produced with R-Project statistical package. Also, I discuss
the application of DCS as a bedside brain function clinical monitoring and its
potential advantages in intensive care units.
Chapter 6 describes the effect of the Obstructive Sleep Apnoea syndrome on
the microvascular cerebral blood flow. To that end, the cerebral vasoreactivity
was studied in a large number (n=83) of subjects which were previously selected
and grouped according to the apnoea-hypopnoea index (AHI) (number of apnoea
and hypopnoea events/sleep hour) which is the parameter used to define the
severity of this disease. The study also includes a control group of healthy
subjects. This work focus on the response of these subjects to an orthostatic
stress challenge. A complete analysis of this data is presented in this chapter by
delivering the mean values of rCBF for each patient group at a given head-of-
bed (HOB) angle and exploring the correlations of rCBF with other clinical and
demographic parameters through LME models.
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Chapter 7 summarizes the conclusions of this Thesis including a global dis-
cussion of the utility and convenience of DCS as a fast portable brain monitoring
diagnose tool.
2
Theory
When shinning infrared light into tissue, the propagation of photons is mainly
dominated by scattering rather than absorption. In this scenario, there are
three important length scales to be considered. The first one is the scattering
length, which is the typical distance traveled by a photon before it experiments
a scattering event, and its reciprocal is the scattering coefficient µs (cm−1). The
second one is the transport mean free path or random walk (ltr), which is the
typical distance traveled by a photon before its direction is randomized. The
reciprocal of this distance is the reduced scattering coefficient µ′s (cm−1). Finally,
photons can also be absorbed in the medium and therefore the absorption length
is the typical distance traveled by a photon before is absorbed, being its reciprocal
the absorption coefficient µa (cm−1) [34]. These coefficients are wavelength
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dependent and they provide with the optical properties of the medium used
to described the light propagation through the diffusion model. This method,
also know as Diffuse Optical Spectroscopy (DOS) or Near-Infrared Spectroscopy
(NIRS) allows to separate the effects of scattering from absorption.
There are three NIRS modalities based on three type of sources as illustrated
in Figure 2.1. The first and simplest one is called Continuous-Wave (CW) and
it consists in projecting continuous-wave light into a diffuse medium (tissue for
instance) and to measure the attenuated outgoing light intensity [26,40–46]. This
is the simplest approach but it provides with the lowest information per source
detector pair and the absolute value of µa and µ′s are difficult to determine.
The second type of source is the Frequency-Domain (FD) where a intensity
modulated source produces a sinusoidal diffuse wave with angular frequency ω
(f = 2piω typically around 100 MHz). In this case, the absolute value of both the
absorption and scattering coefficients can be obtained by analyzing the change
in the amplitude and phase shift of this modulated outgoing light beam [47–51].
Finally, the Time-Domain (TD) or Time-Resolved Spectroscopy (TRS) uses
light pulses containing a range of modulation frequencies. When coming out from
tissue, these light pulses are attenuated and broadened due to the multiscattering
events they experience and from the analysis of their shape the absolute values
of µa and µ′s can be determined [52–56].
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Figure 2.1: Three types of sources for NIRS. In red incoming light in tissue, in
blue outgoing light from tissue. Top: Continuous-wave (CW) where attenuated
signal of the light intensity is monitored. Middle: Frequency-domain (FD) where
the amplitude and the phase shift of the output modulated light are monitored.
Bottom: Time-domain (TD) where the broadening and the amplitude of the
pulse are monitored
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2.1 Photon Diffusion in Turbid Media
The light transport theory in a turbid media can be described through the
radiation transport equation (RTE). Under some approximations, the RTE can
be simplified to the photon diffusion equation [57,58] where the photon fluence
rate Φ(Wcm−2) obeys:
∇·(D(r)∇Φ(r, t))− vµa(r)Φ(r, t)− ∂Φ(r, t)
∂t
= −vS(r, t), (2.1)
where:
D(r) =
v
3(µ′s(r) + µa(r))
D(r) is defined as the photon diffusion coefficient where v is the speed of the
light in the medium.
The validity of the photon diffusion model lays in considering two assumptions
[59]. The first one involves the radiance to be nearly isotropic and this condition
is achieved when µ′s >> µa and the photon propagation distances are larger
in comparison to the transport mean free path, ltr. In this case, the source-
detector distance must be larger than 3ltr [58]. The second assumption implies
that the time variations in the diffuse flux vector ~J are slow i.e this variations
are negligible with respect to the vector itself.
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2.2 Diffuse photon density waves (DPDW’S)
Since part of the experiments explained in this thesis were carried out using a
frequency domain NIRS device, I will develop the following theoretical section
from a frequency domain approach. In this case, we can consider a intensity
modulated source that induces fluence rate disturbances which can be described
as waves or Diffuse Photon Density Waves (DPDW) that oscillate at the same
frequency ω as the source [60,61]. In this scenario, we can assume that the source
term in Eq. (2.1) has ’dc’ and ’ac’ terms and can be expressed as:
S(r, t) = Sdc(r) + Sac(r)e
−iωt
Correspondingly, the oscillating ’ac’ term of the fluence Φac can be expressed
as:
Φac(r, t) = U(r)·e−iωt (2.2)
By substituting this expression in Eq. (2.1) we obtain the diffusion equation
with modulated source:
∇·(D(r)∇U(r))− (vµa(r)− iω)U(r) = −vSac(r) (2.3)
Depending on different geometries and distribution of optical properties,
Eq. (2.3) can be solved either analytically or numerically. In the following section
we consider one such simple geometry which is the infinite medium.
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2.2.1 Photon diffusion in infinite, homogeneous turbid me-
dia
This is the simplest geometry and it is based on considering a single modulated
point source at the origin. In this case, the intensity falls to zero at infinity
because Sac(r) = Sacδ(r) and the solution for the fluence rate adopts the form
of an overdamped spherical wave:
U(r) =
vSac
4piDr
·e−kr (2.4)
Where the complex wave vector k = kr + iki has real and imaginary parts,
both dependent of the modulation frequency ω, the absorption coefficient µa and
the reduced scattering coefficient µ′s as in the form:
kr = (
vµa
2D
)
1/2
[
(1 + [
ω
vµa
]2) + 1
]1/2
(2.5)
ki = (
vµa
2D
)
1/2
[
(1 + [
ω
vµa
]2)− 1
]1/2
(2.6)
2.2.2 Photon diffusion in semi-infinite, homogeneous tur-
bid media
Although the solution for the fluence rate derived from the infinite medium
geometry provides with a description of the propagation of DPDW within the
medium, most of experiments present an interface between tissue and air. In
this scenario, tissue can be modeled as a semi-infinite medium and boundary
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conditions can be used to solve the photon diffusion equation in the reflection
geometry using the method of images [62]. In this case, the fluence rate at the
interface adopts the form:
Φ = zbnˆ · ∇Φ (2.7)
This is known as the partial-flux boundary condition where, nˆ is a vector
normal to the tissue surface and:
zb =
2ltr(1 +Reff )
3(1−Reff )
where Reff being the air-tissue effective reflection coefficient which adopts
the form:
Reff ≈ −1.440n2 + 0.710−1 + 0.668 + 0.00636n
and n = nin/nout the index of refraction ’inside’ and ’outside’ ratio.
The second boundary condition comes from considering a negative source
located at a distance z = −(2zb + ltr) that as a result will make the fluence rate
equal to zero at a distance z = −zb outside the tissue as described in Figure 2.2.
This is called the extrapolated-zero boundary condition and it is expressed
as:
Φ(z = −zb) = 0
Theory 16
Source +1 Image -1 
Z= - Zb 
Z= ltr 
Z= - (2Zb + ltr) 
Air Tissue 
Extrapolated-
Boundary 
Z= 0 
r 
Source  
Fiber 
Detector  
Fiber 
Figure 2.2: Semi infinite medium in the reflection geometry. By using the method
of the images we can consider a negative source located at a distance z =
−(2zb + ltr). As a result, the fluence rate will be equal to zero at a distance
z = −zb outside the tissue.
In case of homogeneous media we can consider D(r) and µa(r) to be a constant
and therefore Eq. (2.8) takes the form:
(∇2 − k2)U(r) = −v
D
·Sac(r) (2.8)
Where,
k2 =
(vµa − iw)
D
.
The frequency domain Green’s function G0(r, rs) also satisfies the expression:
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(∇2 − k2)G0(r, rs) = −δ(r − rs) (2.9)
Thus, by calculating the Green’s function on a given geometry we can solve
the photon diffusion equation.
For the semi-infinite medium geometry the diffusion Green’s function in the
frequency domain adopts the form (in cylindrical coordinates being ρ the radius
of the cylinder):
G0([ρ, z], [ρs = 0, zs = ltr]) =
1
4pi
[
e−kr1
r1
− e
−krb
rb
]
(2.10)
Where:
r1 =
√
(z − ltr)2 + ρ2 (2.11)
rb =
√
(z + 2zb + ltr)
2 + ρ2 (2.12)
By then comparing Eq. (2.10) with the solution for the infinite medium in
Eq. (2.4), it is straight forward that the fluence rate in the reflection mode over
the tissue surface adopts the form:
U(ρ, z = o) =
vS0G0([ρ, z = 0], [ρs = 0, zs = ltr])
D
(2.13)
In the limit when ρ (ltr + 2zb) the solution takes the form:
U(ρ, z = o) =
A0e
−krρ
ρ2
ei(−kiρ+θ0) = A(ρ)eiθ(ρ) (2.14)
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and the following expressions for the amplitude and phase can be obtained:
ln(ρ2A(ρ)) = −krρ+ lnA0 (2.15)
θ(ρ) = −kiρ+ θ0 (2.16)
By measuring the outgoing amplitude and phase at different distances we
can fit previous Eq. 2.15-2.16 to obtained ki and kr which in combination of
Eq. 2.5-2.6 allow us to obtain the absorption and scattering coefficients at a
given wavelength.
The absorption coefficient is related to the chromophores concentration
through the following linear relation:
µa(λ) =
∑
i
i(λ)ci, (2.17)
where λ is the light wavelength, i(λ) and ci are respectively the extinction
coefficient and the concentration of the ith chromophore.
By determining the absorption coefficient at different wavelengths we can
obtain the concentration of important chromophores like the oxy- and deoxy-
hemoglobin, water and lipids. In fact, the use of as much wavelengths as possible
will improve the general output of the concentration of the chromophores. How-
ever, due to practical reasons, in this study we have focused on 690, 785 and
830nm as can be seen in the following chapter. Therefore, the concentration of
oxy- and deoxy-hemoglobin (CHbO2 and CHb) can be obtained from which the
total hemoglobin concentration (also known as blood volume) can be derived:
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THC = CHb + CHbO2 (2.18)
Similarly, the blood oxygen saturation Yt can be estimated by using the
expression:
Yt =
[
CHbO2
THC
]
× 100 (2.19)
2.3 Diffuse Correlation Spectroscopy
When a laser beam is used to illuminate a rough surface, the light will be reflected
in many directions. This reflected light will be composed by bright and dark spots
called speckles as a result of the constructive and destructive interference cause
by the different photon path lengths [63]. If instead illuminating a rough surface
we shine the laser light into a turbid medium (like tissue for instance), the speckle
pattern collected in a detector will fluctuate in time due to the motion of the
scatterers. Diffuse Correlation Spectroscopy (DCS) [64,65] was originated from
Dynamic Light Scattering (DLS) [66] theory and uses the temporal fluctuations
of near-infrared light to study the dynamics of a turbid medium like tissue.
There are two main regimes to take into account depending on whether
photons experiment a single scattering event or if they propagate into the medium
through multiple scattering experience.
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2.3.1 Single scattering limit
In this first approach, we consider a long coherence laser source that shines
light into a dilute solution of particles in suspension where photons scatters
once or not at all as they travel through it. The scattered light is collected in a
detector placed at an angle θ respect to the incident light beam as illustrated in
Figure 2.3.
I(t) 
Time 
q 
APD kin 
kout 
Laser 
Figure 2.3: Schematic description of a single scattering experiment where the
scattered light is collected in a detector placed at an angle θ respect to the
incident light beam.
In the detector, the electric field is a superposition of all the scattered electric
fields and takes the form:
ET (t) = eˆ E0 F (θ) e
−iwt ei(koutRd−kinRs)
 N∑
i=1
e−iqri(t)
 (2.20)
Where eˆ is a unit vector that indicates the polarization direction of the
scattered light, E0 is the amplitude of the incident field, F(θ) is the scattering
form factor and ω is the light angular frequency. Rs, Rd and ri indicate the
Theory 21
positions of source, detector and ith scatterer respectively. The momentum trans-
fer is represented by q = kout − kin where kin and kout the input and output
wavevectors.
If we consider independent, randomly positioned particles with uncorrelated
random motion, the normalized electric field temporal autocorrelation (g1) at
the detector [66,67] takes the form:
g1(τ) =
〈
E(t)E∗(t+ τ)
〉〈 |E(t)|2〉 = eiωτ e−q2
〈
∆r2(τ)
〉
/6
(2.21)
Where ’τ ’ is the correlation delay time, <> represents the ensemble average
and
〈
∆r2(τ)
〉
the particle mean square displacement in time τ . Depending on
the type of motions carried out by the scatterers,
〈
∆r2(τ)
〉
adopts different
expressions:
•
〈
∆r2(τ)
〉
= 6Dbτ for ’Brownian Motion’
•
〈
∆r2(τ)
〉
=
〈
V 2
〉
τ2 for ’Random Flow’
Where Db is the particle diffusion coefficient and
〈
V 2
〉
is the second moment
of the particle speed distribution.
However, experimentally we measured the normalized intensity temporal
autocorrelation function (g2) which takes the form:
g2(τ) =
〈 I(t)I(t+ τ)〉
〈 I(t)〉2
(2.22)
The normalized field autocorrelation function g1(τ) is related to the normal-
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ized intensity autocorrelation function g2(τ) through the Siegert relation [68]:
g2(τ) = 1 + β|g1(τ)|2 (2.23)
where β is a parameter that depends on the number of speckles detected, the
coherence length and the laser stability. The above mentioned Siegert relation
is valid for stationary Gaussian sources as in the case described in this section
where the medium converts the laser light into a Gaussian source. Also, the
medium is ergodic as the time average is equivalent to the ensemble average in
this case.
2.3.2 Multiple scattering limit
If in the previous example, we increase the concentration of scattering particles,
photons will experience many scattering events before they exit the medium as
illustrated in the reflection geometry example of Figure 2.4.
In this case, a photon reaches the detector located at a distance ρ after
experiencing multiple scattering events and the accumulated phase of the electric
field for this photon can be expressed as:
E(t)one path = eˆ E0 e
−iwt ei(kN+1·Rd−k1Rs)
N∏
j=1
F (θj)
N∏
j=1
e−iqjrj(t) (2.24)
Similar to the single scattering limit case, F(θj) is the form factor and θj
the scattering angle for the jth scattering event. N is the number of scattering
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Figure 2.4: Example of the photon path during multi scattering events in the
reflection geometry. A photon reaches the detector located at a distance ρ after
experiencing multiple scattering events.
events along the photon path.
In the detector, the total scattered electric field will be the sum of all the
fields due to all photon paths and can be expressed as:
ET (t) =
All paths∑
E(t)one path (2.25)
If we assume that the individual photon paths are uncorrelated, the total
temporal field autocorrelation function can be expressed in terms of the field
autocorrelation for each individual photon path and therefore takes the form :
g1(τ) =
All paths∑
k=1
Pk · g1(τ)kth path (2.26)
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where Pk is the probability of the kkth photon path.
Following a similar derivation than Eq. 2.21 and considering an homogeneous
highly scattering medium where scattering events are independent and scatterer
displacements are uncorrelated, the temporal field autocorrelation for one photon
path takes the form:
g1(τ)one path = e
iωτ e
− 13k02Y
〈
∆r2(τ)
〉
(2.27)
and
Y = N · (1−< cosθ >N )
In highly scattering medium this parameter can be approximated to the
number of random walks associated to a photon path and it takes the form:
Y =
s
ltr
(2.28)
where ‘s’ is the total photon path length.
In the detector, the field autocorrelation function contains the contributions of
all the photon paths and can be expressed as a function of the photon pathlength
distribution P(s):
g1(τ) = e
iωτ
∫ +∞
0
P (s) e
−s
3ltr
k0
2
〈
∆r2(τ)
〉
ds (2.29)
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2.3.3 Correlation diffusion equation
The correlation photon diffusion equation [30,69] can be derived from the corre-
lation transport equation (CTE) and takes the form:
[
∇·(D(r)∇)− vµa(r)− 1
3
µ′sk20
〈
∆r2(τ)
〉]
G1(r, t) = −vS(r, t) (2.30)
Where G1 is the unnormalized electric field correlation function and k0 = 2pi/λ
is the wave vector of the incident CW light. The Green’s function solution for
Eq. (2.30) in the homogeneous semi-infinite medium geometry takes then the
form:
G1(ρ, z, τ) =
3µ′s
4pi
[
exp(−K(τ)r1
r1
− exp(−K(τ)rb
rb
]
(2.31)
Where,
K(τ) =
√
3µ′sµa + µ′s2k20α
〈
∆r2(τ)
〉
taking r1 and rb the form given in Eq. (2.11-2.12). The parameter α is the
fraction of scattering events from moving scatterers (mainly red blood cells)
as biological tissue contains also static or very low scatterers like organelles or
mithocondria.
In the tissue surface (z = 0) the normalized temporal electric field correlation
g1(τ) = G1(ρ, τ)/G1(ρ, 0) will take the form:
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g1(ρ, τ) =
(
exp(−K(τ)r1
r1
− exp(−K(τ)rbrb
)
(
exp(−K(0)r1
r1
− exp(−K(0)rbrb
) (2.32)
In a measurement we obtain the normalized temporal intensity autocorre-
lation g2(τ) from which we can derived the normalized temporal electric field
correlation g1(τ) using the Siegert relation. Then by fitting the temporal decay of
g1(τ) for a given source detector separation we can obtain K
2. This is illustrated
in the example of Figure 2.5.
Figure 2.5: Example of g1 values (in red) measured in tissue versus the delay
time τ . In blue, the fitting curve from which we obtain the
〈
∆r2(τ)
〉
.
From this fitting, the
〈
∆r2(τ)
〉
is finally obtained which contains the dynamic
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information of the medium.
Since DCS signal is obtained from the microvasculature of a tissue volume,
a random flow model (
〈
∆r2(τ)
〉
=
〈
V 2
〉
τ2 ) was adopted to fit the decay of the
measured correlation curves. However, it was found [31, 32, 35] that Brownian
model (
〈
∆r2(τ)
〉
= 6Dbτ ) is more appropriate for such purpose being this
model validated in a wide range of animal and human tissues like muscle, brain
or tumors.
Although αDb is not a measurement of the absolute blood flow, it is referred
as ’Blood Flow Index’ (BFI) as it correlates well with other blood flow modalities.
Furthermore, the relative blood flow (rBF) is an index obtained by normalizing
the blood flow index (BFI) with a given baseline value which reflects how the
blood flow has change in % respect to the baseline values.
rBF = (
BFI
BFIbaseline
− 1)× 100 (2.33)
If the sampling tissue is brain, equation 2.33 uses relative cerebral blood flow
(rCBF) instead of rBF. We will use this final parameter to describe the results
obtained in the following chapters.
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3
Instrumentation
In this thesis, I have used DCS and Frequency Domain NIRS devices to obtain
values for the CBF and oxy- and deoxy-hemoglobin concentration respectively.
Thus, depending on the needs of the experimental design, I have used single DCS
devices (Chapters 4 and 5) or hybrid devices, result of combining both DCS and
FD NIRS equipments (Chapter 6). In any case, since most of the research carried
out on this thesis was done in hospital premises, all the set ups were adapted to
be portable.
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3.1 Diffuse Correlation Spectroscopy device
The schematic description of the functioning of the DCS device used is illustrated
in Figure 3.1.
Correlator 
g2(t) 
Siegert Relation 
Fitting g1(t) 
aDb = Blood 
Flow Index 
Laser 
Source 
Detector 
r 
Intensity fluctuations 
g1(t) 
Tissue 
Figure 3.1: Schematic description of the functioning of DCS: Due to incident NIR
laser light, photons experiment a set of scattering events that induce a phase
change in the electric field of their waves. In the detector the light intensity
oscillates in time. An autocorrelator uses the output of the detector to produce
the normalized temporal intensity autocorrelation function (g2). By using the
Siegert relation, the electric field temporal autocorrelation function (g1) is derived.
By fitting g1 the blood flow index (αDb) is finally extracted.
In the experiments I shined light into the tissue by using a long coherence
laser source at 785nm (120mw, Crystalaser, Reno, Nevada, USA) through a
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multimode fiber of 200µm diameter core. The light was collected using 8 single
mode fibers of 5.8µm core diameter and sent into two arrays of 4 Excelitas
Technologies (Dumberry, Vaudreuil, Canada) single-photon counting avalanche
photodiodes (SPCM-AQ4C) conforming 8 (2x4) detectors. The output of each
detector was used to build the normalized intensity autocorrelation function by
using an 8 channel correlator (Correlator.com, Bridgewater, New Jersey, USA).
Also, an optical switch was used in these studies when required.
Depending on the nature of the experiment carried out, different source detec-
tor geometries were used and therefore different optical probes were manufactured
which will be explained in detail in the following sections of this chapter.
3.1.1 Rat Brain Probes
In this project, I have developed two similar optical probes based on the features
of a rat skull of 6 months old illustrated on Figure 3.2. In both cases, the probe
placement area was the (yellow) top flat part of the skull. The main reference
point used was Bregma (the intersection of sagital and coronal sutures). The
dimensions (11 x 11 mm) are in this case orientative as they change in time.
The first probe developed was an implantable probe and the second one a
surface probe version which involved a brief alteration of its geometry as can be
seen on Figure 3.3 where both geometries designs can be compared.
As it will be explained in detail in Chapter 4, the justification for this brief
alteration comes from taking into account the thickness of the rat scalp (around
1mm), the fat accumulation and the natural growth of the animal. The reason of
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Figure 3.2: 6 months old rat skull with key landmarks (Bregma and Lambda
points) and orientative dimensions. The probes placing area (yellow) is located
on the top flat part of the skull.
having many source-detector pairs was to be able to monitor different volumes
of the rat brain at different depths.
In both cases, I have used Bregma point (in red on Figure 3.3) as a reference
point to properly placed the probes over the skull and the scalp respectively.
3.1.1.1 Implantable Probe
This probe consisted of two platforms with holes for fiber placement following the
geometry described in the left side of Figure 3.3. The purpose of this geometry
was to track different parts of the brain at different depths and locations.
The lower platform was implanted on the rat skull using Bregma point as a
reference after removing the rat scalp. The optical fibers for both sources and
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Figure 3.3: Comparison of implanted and surface probe geometries. The differ-
ences in the source-detector distances were motivated after taking into account
the depth of the scalp, the fat accumulation and the natural growth of the animal.
detectors were located in the upper platform of the probe and fixed in their
position with small screws. Finally both parts were put one to the other as
shown in the diagram of Figure 3.4 becoming a single probe. At the end of each
study session, the upper platform was removed leaving the lower platform in
place.
This approach presents some advantages in terms of accuracy in positioning
the probe in the correct place over the skull and it can stay on the rat head over
long periods of time without changing its location. Also, it avoids the partial
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Figure 3.4: (Left) Description of the two stage platforms of the implantable
probe and its placement on the skull. (Right) Picture of the implantable probe
on rat during a measurement.
signal derived from the scalp and therefore reduces the signal to noise ratio. The
lower implanted platform was made MRI compatible to allow its use alternatively
during fMRI and DCS experiments.
On the other hand, the scalp must be removed to implant the probe and that
derives into a surgical intervention [29,70–76] with its inherent healing process
which involves to often clean the fiber holes of the lower platform . Also, the
living condition of the animals generally worsens as they are more vulnerable to
suffer infections.
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3.1.1.2 Surface Probe
The surface probe consisted of a single platform with holes for fiber placement
which follow the geometry description of the right side of Figure 3.5. As before,
the purpose of this geometry was to track different parts of the brain at different
depths and locations.
Figure 3.5: Left: Imaginary representation of the probe over the rat skull. Center:
Overview of the surface probe. Right: Overview of the probe merged into the
metallic shield.
This platform was merged with metallic cover shield with the purpose of
avoiding light contamination and to integrate the probe into an estereotaxic arm
which allowed us to move very precisely the probe in the space.
In comparison to the implanted probe, the surface approach is fully non-
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invasive and therefore surgical interventions are not required. In this scenario,
animals were simply shaved with an electric razor and depilatory cream to avoid
side effects of the fur. Since I had no visual access to Bregma, the main difficulty
laid on placing the probe over the scalp in the correct place. However, a set
of steps were developed to enhance the accuracy of this process that will be
explained in detail in Chapter 4.
3.1.2 Human Forehead Probe
Based on prior studies [33, 77], the optical probe developed for studying the
hemodynamics of ischemic stroke patients was constructed with a flexible hy-
poallergenic material that allowed to be adapted to the shape of the forehead.
This probe was conformed by two symmetric sets of source-detector pairs at
2.5cm distance placed on both right and left frontal hemispheres as described
on Figure 3.6. Due to the characteristics of this study, I have used custom made
optical fibers with 90◦ bend tips. Each set of detectors collected the light into
four avalanche photodiodes detectors to be averaged when processing the data.
1Human 3-D plot courtesy of Hemophotonics. S.L (http://www.hemophotonics.com/)
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Detector Detector 
Source Source 
Figure 3.6: Sketch1of the human forehead probe use to study the hemodynamics
of ischemic stroke patients. The probe was composed by two symmetric sets
of source-detector pairs at 2.5cm distance placed on both right and left frontal
hemispheres.
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3.2 NIRS device
Figure 3.7 describes the functioning of a FD NIRS device where modulated light
at 110Hz is shone into tissue at three different wavelengths. By measuring the
change in amplitude and phase of the outgoing light at different source-detector
distances both absorption and scattering coefficient can be determined.
690 nm 
785 nm 
830 nm 
110 Hz 
DC/AC 
Phase 
ma, ms’ 
Tissue 
Source 
Detector 
Figure 3.7: Schematic description of the functioning of a Frequency Domain NIRS
device. A modulated (110Hz) light source (in red) is used to shine tissue using
three different wavelengths alternatively (690, 785 and 830nm). The outgoing
light (in blue) is collected in a detector at a given source-detector distance.
By analyzing the intensity attenuation of this signal and its phase shift, the
absorption (µa) and scattering (µ′s) coefficients can be determined.
For the experiments where I wanted to obtain the optical properties of the
tissue, I have used a commercial FD NIRS device (Imagent, ISS, Illinois, USA)
which was composed of 15 (5x3) laser sources organized in groups of 5 sources
at three different wavelengths (690, 785 and 830nm respectively) and modulated
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at 110Hz. The light was collected in two photomultipliers and by fitting the
amplitude and the phase of the outgoing light, µa and µ′s were calculated.
3.3 Hybrid Instrumentation
Measuring simultaneously the static and dynamical properties of the tissue can
provide with very useful information about the blood flow and blood oxygenation.
With this purpose, others in the past have built hybrid devices for many different
purposes [31,36,78,79].
In this study, I have utilized a portable set-up (Figure 3.8) composed by a
DCS and a FD NIRS (ISS-Imagent). Both devices were designed to be portable
allowing bedside monitoring and to work independently (controlled by indepen-
dent computers) although they were interconnected when proceeding with a
measurement. Accordingly, both measurements were synchronize and any event
marked with DCS (like for instance a change in the head-of-bed) was also regis-
tered by the ISS-imagent device.
3.3.1 Sleep Study Probe
This optical probe was constructed with a flexible hypoallergenic material to be
adapted to the shape of the forehead of the patients and was conformed by two
sectors as shown in Figure 3.9a. The first one located over the right forehead of
the patient was used for DCS measurements whereas the one in the left forehead
was devoted to FD NIRS.
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DCS Set Up NIRS Set Up 
DCS 
Battery 
ISS Imagent 
Figure 3.8: Picture of the hybrid portable set up. (Left) DCS device. (Right)
ISS Imagen FD NIRS device.
The DCS part consisted in one laser source and two sets of detectors located
at 1 cm and 2.5 cm far from the source as illustrated on the left side of Figure 3.9a.
Each set of detectors collected the light into four avalanche photodiodes detectors
to be averaged when processing the data.
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DCS Light 
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DCS Detectors 
ISS Detector 
ISS Light 
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ISS Light 
Sources 
ISS Detector 
“Suspension Bridge” system 
(a) View of the hybrid optical probe constructed with a flexible
hypoallergenic material and composed by two sectors, one for the
DCS probe (left) and the other for the NIRS one (right).
S1 
S2 
S3 
S4 
S5 
D1 D2 
2.5 cm 
(b) Diagram of the self-calibrated NIRS probe. Sources in red are
equidistant to detector one (in the left, in blue) but they present
different distances to the second detector (in the right, in blue)
Figure 3.9: Description of the hybrid probe.
In the design of the NIRS probe (right side of Figure 3.9a) I took into account
several factors that could lead to error in estimating µa and µ′s like for instance the
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poor contact between the fiber tips and the tissue or also the fiber imperfections.
These factors are the so-called coupling errors [80] and can be expressed through
coupling coefficients for both the sources and detectors fibers. I have used of
a self calibration method [50] to obtain the relative values of all the coupling
source coefficients using the sources equidistant to one detector as illustrated in
Figure 3.9b. These coefficients were introduced in the measurements of the other
detector from which µa and µ′s were fitted by minimizing the χ2 using nonlinear
least square curve fitting.
4
Non-invasive monitoring of functional
activation in rat brain with DCS
4.1 Introduction & motivation
Brain is a complex organ organized through interconnected areas responsible
for different functions. Blood flow is delivered in the brain through three main
vessels (i.e. 2 carotid arteries and the basilar artery) that leads blood to the circle
of Willis where the main cerebral arteries branch out [81]. There are three main
vascular territories that guarantee the blood flow delivery in the brain through
the anterior cerebral artery (ACA), the middle cerebral artery (MCA) and the
posterior cerebral artery (PCA). Among them, MCA takes center stage in the
study of ischemic stroke as around 50% of them are produced when there is a
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partial or total occlusion in the middle cerebral artery (MCAO) [82]. Depending
on the severity of these type of strokes, the impact over a relatively large brain
area can be huge, includying the motor and the somatosensory areas. This last
one is of great interest in the neuroscience community for the study of stroke
models, stroke recovery therapies and the design of new pharmacological drugs
among some other reasons.
Neurovascular coupling is the relation between neuronal activity and cerebral
blood flow increase in the microvasculature [83]. This is a complex mechanism not
fully understood where neuronal activity implies energy consumption, producing
a demand of oxygen and glucose which are carried out through the blood stream.
The understanding of the neurovascular coupling and its alterations after cerebral
pathophysiologies could provide important insights into the management of
different pathological conditions such as ischemic stroke [84].
Electroencephalography (EEG) [85] techniques have been used to study the
cerebral activity, i.e. the electrical activity, in both human and rodents but EEG
signals can be difficult to interpret [86].
The blood oxygen level dependent (BOLD) [22] and arterial spin labeled
(ASL) magnetic resonance imaging (MRI) methods have revolutionized the study
of neurovascular coupling in humans as well as in experimental animals [19,23,
87]. Unfortunately, the high costs of these equipments limits the access of the
researchers to longitudinal studies.
Optical techniques such as laser Doppler flowmetry (LDF) [27,28,75,76], opti-
cal intrinsic signals imaging (OISI) [24,70,71,88,89] and laser speckle flowmetry
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(LSF) [29, 73, 74, 90] have provided relatively low-cost alternatives, albeit with
some compromises, for the study of the neurovascular coupling. One main limi-
tation of these methods is the fact that are limited to superficial measurements
and therefore, in general, require thinning or removal of the skull.
Diffuse optical techniques such as near-infrared spectroscopy (NIRS) and
diffuse correlation spectroscopy (DCS) allow non-invasive measurements of the
cerebral hemodynamics in deep tissues and are even able to reach the human
brain transcranially (through scalp, skull, etc..) [30–35,91–93]. I am particularly
interested in cerebral blood flow measurements in rodents where DCS can be
utilized. Indeed, DCS and NIRS have been utilized in rodents transcranially [94]
with the scalp retracted [79] and longitudinal functional activation has been
demonstrated in mice [44] using a skull implantable fiber optical probe.
However, there are some limitations in this approach. Namely, the retraction
of the scalp created some issues due to the healing of the tissue and repeatability
is a concern due to the growing animal.
In the study of the neurovascular coupling in rodents, the paw (forepaw and
hindpaw) electrical stimulation [95] is one of the most common external stimulus
used to induced a functional activation in the somatosensory areas correspond-
ing to forepaw or hindpaw (represented in orange and yellow respectively in
Figure 4.1).
Within this context, α -chloralose has been extensively utilized as an anes-
thetic in rodents [74, 75, 96–99] as it preserves the neuronal activity and its
hemodynamic response [100]. However, although is found to be an excellent
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Figure 4.1: Areas of activation in the rat brain induced by forepaw stimulation
(orange) and hindpaw stimulation (yellow).
sedative for specific studies, it is unsuitable in longitudinal studies [101].
Alternatively Weber et al. [102] developed a fully non invasive method for
MRI based on the sedative medetomidine [103] and the monitoring of the animals
during experimentation which allows to proceed with longitudinal studies [104–
106].
The main objective of this study was to measure the evoked cerebral activity
in a fully non invasive manner using this anesthesia protocol and to compare the
findings with the results in the literature obtained with BOLD and optical tech-
niques that required invasive methods (i.e removing the scalp and/or thinning
the skull).
In this regards, I have developed two types of optical probes which were
Non-invasive monitoring of functional activation in rat brain with DCS 47
already described in Chapter 3. The implantable MRI compatible probe was
built with the aim of exploring the feasibility of measuring the evoked functional
activation using this particular anesthesia whereas with the surface probe I took a
step forward and I proceeded with fully non-invasive longitudinal measurements.
4.2 Methods
This study was performed in collaboration with Dr. Carles Justicia from the De-
partment of Brain Ischemia and Neurodegeneration of the Institut d’Investigacions
Biome`diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. All the methods
described in this section have been approved by the Ethical Committee of Ani-
mal Experimentation (CEEA) of the Generalitat de Catalunya and they were
applied to all the animals involved on this study.
4.2.1 Anesthesia
Male Wistar rats with a body weight of 320± 50g in the beginning of the study
were anesthetized with 4% isofluorane in O2 : N2 (30:70). After that, animals
were placed in a stereotaxic frame with a face mask delivering the same gas mix
with 3% isofluorane and a subcutaneous bolus of 0.05 mg/Kg of medetomidine
(Domitor, Pfizer) was injected. Isoflurane was slowly discontinued over the course
of the next 15 min at a rate of approximately 0.25% every 1 min starting 3
min after the bolus administration. Therefore, isoflurane is presumed to not be
available at 15 min after the bolus administration. At this point, a continuous
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subcutaneous infusion of medetomidine (1ml/h; 0.1 mg/Kg) was initiated for
the whole duration of the experiment. The forehead of the animals was shaved
using an electric razor and depilatory cream to avoid side effects in the optical
signal produced by the fur. Two subdermal electrode needles were inserted
in both forepaws for stimulation. The respiration rate (number of respiration
per minute) was registered every 5 minutes and the body temperature was
continuously monitored with a rectal probe and maintained around 37◦C with
in-house feedback controlled electrical blanket.
Around 30 minutes after the bolus injection, animals already washed out most
of the isofluorane and they presented a stable condition with a respiration rate
of approximately 50% compared with the initial respiration rate once the animal
was anesthetized. The body temperature was around 37◦C. At this point the
stimulation protocol was initiated (described in next section). When the experi-
ment was concluded the animal received an intraperitoneal injection (0.1mg/Kg)
of atipamezole (Antisedan, Pzifer) to reverse the effect of the medetodimine.
4.2.2 Stimulation
I have used a stimulus paradigm which consisted in a rectangular constant
current stimulus of 15 seconds followed by 45 seconds of recovery period. The 15
seconds stimulus was conformed by a train of pulses of 2mA and 300µs duration.
Depending on the pulse rate used, each stimulus paradigm have the following
features:
• 15 seconds stimulus duration at 3Hz pulse rate (45 pulses) followed by 45
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second of recovery period.
• 15 seconds stimulus duration at 6Hz pulse rate (90 pulses) followed by 45
second of recovery period.
• 15 seconds stimulus duration at 9Hz pulse rate (135 pulses) followed by
45 second of recovery period.
Our protocol consisted in setting a pulse rate and to repeat 5 consecutive
stimulus paradigms using the same pulse frequency. This set of 5 single stimulus
periods conformed a train of stimuli of 5 minutes duration followed by 5 min-
utes of recovery period. These trains of stimuli were applied 3 times per paw
alternatively as illustrated in Figure 4.2.
4.2.3 fMRI experiments
The fMRI experiments were conducted on a 7.0T BioSpec 70/30 horizontal scan-
ner (Bruker BioSpin, Ettlingen, Germany), equipped with an actively shielded
gradient system (400 mT/m, 12 cm inner diameter). The receiver coil was a
4-channel phased-array surface coil for the rat brain. For fMRI studies, coronal
multislice spin-echo (SE) EPI images were acquired using the following param-
eters: TE/TR = 30/3000 ms; BW = 150 kHz; 5 consecutive slices of 2 mm
thickness; Field-of-view = 2.56 x 2.56 cm2; matrix of 64 x 64 pixels. Functional
activation imaging was achieved with BOLD contrast MRI. Statistical paramet-
ric activation maps were constructed with the software STIMULATE [107]. Time
course for each pixel was examined using a paired Student’s t-test (P < 0.01).
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Figure 4.2: Diagram of the protocol followed to electrically stimulate the forepaw
of the rat. Each stimulus paradigm consisted in 15 seconds stimulation followed
by 45 seconds of recovery period. The stimulation was conformed by train of
pulses of 2mA and 300µs duration. Different pulses rates of 3, 6 and 9 Hz were
used depending on the experiment. 5 consecutive stimulus paradigms conformed
a train of stimuli of 5 minutes duration followed by 5 minutes of recovery period.
The trains of stimuli were applied 3 times per paw alternatively
4.2.4 Blood flow response from the optical signal
An optical switch was used to alternatively acquire data from both brain hemi-
spheres. The averaging time for each single measurement was of 500ms which
implies to have a temporal resolution of 1 sec per brain hemisphere.
The use of the implantable probe allowed to be very precise in measuring
the correct region of interest. However, when I used the surface probe I had no
visual access to Bregma and a set of steps were followed to properly placed the
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probe over the rat scalp. This protocol is schematically explained on Figure 4.3
and it basically consisted in using a transparent plastic grid referenced to a set
of landmarks (eyes, ears and nose) from which the location of Bregma point
can be estimated. Distances in the plastic grid were modified according to the
growth of the animal.
A 
B 
C 
Figure 4.3: Description of the surface probe positioning protocol over the rat
scalp
Two circles were plot (Figure 4.3-A) marking the projection of the laser
beams over the scalp (Figure 4.3-B) to secure the correct positioning of the
probe. By carefully monitoring this process, the probe was finally firmly placed
over the scalp applying sufficient pressure to assure a good probe-scalp contact
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as shown in Figure 4.3-C.
Due to the fact that animal physiology can change during the measurement,
the blood flow response was calculated separately for each trains of stimuli. The
relative cerebral blood flow (rCBF) was obtained by normalizing the blood flow
index (BFI) of a given train of stimuli with a baseline obtained by averaging
the means of the BFI corresponding to the 15 seconds prior to the start of the
electrical discharge inside that train.
Characterization of the mean blood flow signal
The 15 (5x3) blood flow responses produced per paw per measurement were
averaged. As a result, a final averaged rCBF signal was obtained which reflects the
average blood flow response to electrical stimulation for the whole measurement.
In order to evaluate the strength of the averaged rCBF, I have followed the
same protocol described in [75] to estimate its peak height i.e the maximum
change in amplitude when compared to baseline values. This was performed by
locating the maximum value of the signal and averaging the data from 1 sec
prior to 1 sec posterior to the maximum amplitude.
In some occasions, the blood flow response to a given stimulus was weak and
could not be distinguished from the noise levels which were observed to oscillate
in a range of ±10% during the resting periods between trains of stimuli. Therefore,
a selection criteria was introduced to differentiate the blood flow response from
noise. This criteria establishes that the evoked functional activation is observed
if there is a minimum of 15% in blood flow increase for all the stimulus within
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at least one train of stimuli when compared to baseline values. All the averaged
rCBF results described in the next section have been derived from measurements
that accomplish the above mentioned criteria.
4.3 Results
4.3.1 BOLD results with stimulus pulses at different fre-
quencies
All the individuals in this study were subjected to fMRI and anatomical imaging
by MRI two weeks before proceeding with the optical measurements. The evoked
response was evaluated with fMRI using stimulus pulses at a rates of 3, 6 and
9Hz which were randomly applied on each set of stimuli (the same frequency
was used in the five consecutive stimulus that conformed a train of stimuli. After
this, another frequency was selected).
The main plot of Figure 4.4 represents the averaged BOLD signals produced
at the mentioned frequencies in the left brain hemisphere versus time. As we
can see, the averaged signal produced at 9 Hz (in blue) presents the maximum
amplitude closely followed by the signal produced at 6Hz (in green). When
comparing these two signals it can be seen that the one produced at 6Hz decays
slower during the stimulation time. Finally, the signal produced at 3Hz (in red)
presents the lowest amplitude and also seems to decay slower than the 9Hz signal.
The small plot in the right side is an example of the activation map produced
by one of these stimulus.
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Figure 4.4: (Main) Example of BOLD signal produced at 3, 6 and 9 Hertz
stimulation (in grey). (Right) Example of the activation map produced by one
stimulus in the right forepaw.
4.3.2 Implantable Probe
Three rats were measured following the anesthesia and electrical protocol de-
scribed previously. The evoked functional activation was obtained for all the
specimens with stimulus of 3Hz pulse rate.
An example of these results can be seen in Figure 4.5 where the blood flow
response to 3Hz stimulation is presented versus time. In this plot, we can seen
how the average rCBF stays constant during the baseline period until the start
of the stimulus. When that happens, the average rCBF experiments an increase
of around 40% compared to baseline values and starts decreasing still during the
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stimulus duration. When the stimulus is finished, the signal returns to baseline
values. This result has features similar to the flow signals obtained in similar
experiments described in the literature [97,98]. This fact encouraged us to go a
step further and to explore the feasibility of the surface probe.
Figure 4.5: Example of the average rCBF (errorbars=std) versus time (sec) in
the right hemisphere of one animal with the implantable probe at 3Hz electrical
stimulation (in grey). The average rCBF stays constant during the baseline
period until the start of the stimulus. When that happens, the average rCBF
experiments an increase of around 40% compared to baseline values and starts
decreasing still during the stimulus duration. When the stimulus is finished, the
signal returns to baseline values
Non-invasive monitoring of functional activation in rat brain with DCS 56
4.3.3 Surface Probe
In this section I present the results obtained with the surface probe in different
sets of experiments according to the age of the animals and following the anesthe-
sia, probe placement and electrical stimulation protocols described previously.
The first set of experiments involves measurements of 6 months old animals
with a body weight of 320 ± 50g carried out during three consecutive weeks in
the beginning of this study. In here, the pulse rate utilized for the electrical
stimulation was of 9HZ. In the second set, animals of 18 moths old with a body
weight of 580 ± 80g were measured during two consecutive weeks using 6Hz
stimulus.
Finally, I will also show a representative longitudinal case of one animal which
was included in both of the previous cohorts.
4.3.3.1 6 months old animals
All the animals presented in this section (n=5) were measured once per week
during three consecutive weeks using stimulus of 9Hz pulse rate. The average
blood flow response was obtained for all the specimens and the peak height was
derived as explained previously. The values obtained for the peak heights in
both hemispheres are represented in Figure 4.6. The results show intra- and
inter-individual variability in the length of the bars (the strength of our signal).
For instance, the signal obtained in the left hemisphere of rat 5 measured in
the second week presents a peak height of 44% and this value was obtained by
averaging the 15 blood flow responses induced by the 15 electrical stimulations
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Figure 4.6: Right (Top) and left (Bottom) hemispheres peak heights versus
animal label in the 6 months old group of animals measured over three consecutive
weeks.
as illustrated in the left side of Figure 4.7.
In this example, the signal to noise ratio is good enough to identify all the
blood flow responses and the final averaged rCBF signal obtained for this animal
is illustrated in the example of Figure 4.8.
In compliance with the results obtained with the implantable probe, we can
see that blood flow stays constant (around 100% in the figure) until the beginning
of the electrical stimulation of 15 second duration (in grey). When the stimulus
starts, the blood flow increases until it reaches its maximum value (52% increase
compared to baseline values). Right after, still within the electrical stimulation,
the flow signal starts decreasing smoothly conforming a plateau phase until the
end of the stimulus. Finally, the blood flow returns to baseline values. The peak
height parameter (44%) was obtained by averaging the data from 1 sec prior to
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Figure 4.7: Example of the three contralateral rCBF trains of stimuli measured
with the surface probe with good signal-to-noise ratio versus the ipsilateral
response corresponding to rat 5 on the second week. The grey areas indicate
the duration of the electrical stimuli (15 sec). Measurement started (time=0) 25
min after the bolus injection.
1 sec posterior to the maximum amplitude. As with the implantable probe, this
signal has features similar to the flow signals obtained in the literature [97,98].
On the other hand, when looking at the peak height of rat 3 in the same
hemisphere and also measured during the same week, we can see that it presents
a value 11%. The reason for this low value compared to the previous example is
illustrated in the left side of Figure 4.9 where we can see the three rCBF trains
of stimuli from which the peak height was derived.
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Figure 4.8: Example of the final averaged rCBF signal (errorbars=std, plotted
every two points) versus time (sec) obtained from the contralateral trains of
stimuli (left hemisphere) of rat 5 during the second week. The grey areas indicate
the duration of the electrical stimuli (15 sec). The averaged rCBF stays constant
(around 100% in the figure) until the beginning of the electrical stimulation.
When the stimulus starts, the blood flow increases very fast until it reaches
its maximum value (52% increase compared to baseline values). Right after,
still within the electrical stimulation, the flow signal starts decreasing smoothly
conforming a plateau phase until the end of the stimulus. Finally, the blood flow
returns to baseline values. The peak height (44% in this case) is obtained by
averaging the data from 1 sec prior to 1 sec posterior to the maximum amplitude.
In this case, the functional activation was observed only in the third train
of stimuli and although the flow response accomplishes with the validity signal
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criteria described previously, the peak height derived is relatively small (11%)
compared to the previous example. The reason for this lays in the fact that the
peak height is derived from the average of all the 15 blood flow responses, with
independence if there was not flow response during the first two trains of stimuli.
1 
2 
3 
CONTRALATERAL IPSILATERAL 
Figure 4.9: Example of contralateral rCBF trains of stimuli (left hemisphere)
versus the ipsilateral response corresponding to rat 3 on the second week. Only
the last train of stimuli induced a functional activation strong enough to be
measured. The peak height derived is relatively small (11%) compared to the
example derived from Figure 4.8 because it was built from the average of all the
15 blood flow responses with independence if the evoked functional activation
was not observed in the first two trains of stimuli. Measurement started (time=0)
25 min after the bolus injection.
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4.3.3.2 18 months old animals
All the animals presented in this section (n=7) were measured once per week
during two consecutive weeks using 6Hz stimulation. The average blood flow
response was obtained for all the animals and the peak height was derived in the
same manner than the previous section. The values obtained for the peak heights
in both hemispheres are represented in Figure 4.10. As before, the intra- and
inter-individual variability shown in the results is caused by the same reasons
explained previously.
Figure 4.10: Right (Top) and left (Bottom) hemispheres peak heights versus
animal label in the old group of animals over two different measurements.
4.3.3.3 Longitudinal study of a representative rat
In the next section I present a longitudinal case of one animal (rat 4) who was
part of both cohorts of 6 and 18 months old experiments described previously.
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The blood flow responses obtained with a year difference at 9Hz and 6Hz stimulus
are compared in Figure 4.11.
3 Weeks 2 Weeks 
1 Year 
6 Months Old 18 Months Old 
Figure 4.11: Left: Average rCBF signal in the right hemisphere of one animal
during three consecutive weeks obtained at 9Hz stimulation frequency. Right:
Average rCBF signal in the right hemisphere for the same animal measured one
year later during two consecutive weeks obtained at 6Hz stimulation frequency.
In the left side of this plot we can see the blood flow responses to 9Hz
stimulation obtained from the measurements carried out with the young rats.
Although some differences in amplitude (within the errorbars), the three signals
are in the same range and have similar shape. One year later, the same animal
was measured during two consecutive weeks (right side of Figure 4.11) and the
blood flow responses to 6Hz stimulation were similar in amplitude and shape.
As an overall, we can see that the blood flow responses obtained from both
sets of experiments are very similar in terms of shape and amplitude although
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this last one presents some attenuation for the older group of rats when compared
to the young one.
Once again, all these signals have features similar to the flow signals obtained
in the literature [97,98].
4.4 Discussion
An initial evaluation of the evoked functional activation was carried out with
fMRI which confirmed a normal physiological condition in all the animals pre-
sented on this study. The use of the implantable probe demonstrates that the
evoked functional activation using this anesthesia protocol [102] can be measured
with DCS. This approach was used in the past with a different anesthesia proto-
col [44,79] and clearly presents some advantages like the low signal-to-noise ratio
due to the absence of scalp or the possibility to visualize the skull to accurately
place the probe over the right areas of interest. Also, the part of this probe which
was fixed to the rat skull was made MRI compatible and therefore it allows to
proceed with both optical and MRI experiments simultaneously.
However, the removal of the scalp made animals more sensitive to get in-
fections and the fact that the probe was clamped to the skull might generate
issues related to the animal growth. Furthermore, this issue is extended to opti-
cal techniques that involve the removal of the scalp or thinning the skull such
as laser Doppler flowmetry (LDF) [27,28,75,76], optical intrinsic signals imag-
ing (OISI) [24,70,71,88,89] or laser speckle flowmetry (LSF) [29,73,74,90]. In
addition to this point, these techniques allow to proceed with superficial mea-
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surements in contrast to the penetration depth of DCS that probes a relatively
large tissue volume.
The surface probe eliminates the issues derived from surgical intervention
and in combination with the absence of side effects in the anesthesia protocol
used it guarantees a fully non-invasive approach which allows to proceed with
longitudinal experiments [102, 104–106]. The results obtained with this probe
present a stronger average rCBF signal in the young group of rats in response
to 9Hz stimulation than the group of old rats with 6Hz stimulation. Also, the
response to 9Hz is very similar to the response achieved at 3Hz stimulation.
Regarding this point, one possibility is that the final signal obtained with the
surface probe is weakened due to the partial volume effect [32, 108] of the rat
scalp.
Within this context, the initial experiments carried out with 18 months old
rats showed a very reduced response at 9Hz stimuli in contrast to stimulations
induced at 6Hz stimulation which provided a clearer and stronger response. This
response was also slower on its decay as shown on the fMRI results of Figure 4.4.
For this reason, I utilized 6Hz as the stimulus frequency for the experiments with
old rats. These differences between blood flow responses at different frequencies
in the old population could be related to anatomical or physiological changes in
the animal provoked by the elderly specimens (18 months old) and also could
be linked to the differences in the peak heights when the young and the old
populations are compared.
In relation to this point, the steps followed to place the surface probe over
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the rat scalp involved using a plastic grid referenced to a set of landmarks that
was designed based on an atlas [109]. One possibility is that the areas of interest
(forepaw somatosensory regions) in the old rats stay out of the volume tracked
by our probe. This could be caused by the growth of the animal which induces
a displacement of our areas of interest [110] along the coronal direction.
Another factor to take into account comes from the fat accumulation on
these old specimens which increases the width of the scalp and therefore it alters
the penetration depth of the probe. Furthermore, dealing with such big animals
presented some extra difficulties in terms of accommodating the animals in the
stereotaxic frame and/or their tolerance to the anesthesia.
The results obtained with the surface probe in both populations did not show
a 100% repeatability in the strength of the blood flow response but there is room
for improvement. For instance, the method developed for probe positioning over
the rat scalp can be implemented and new geometries involving a higher number
of source-detector pairs can be built in future versions of this probe following the
approach of Boas el al. in [99] or Kawasima et al in [111]. In relation to these
points, it is important to highlight that the variability shown on Figs. 4.6 - 4.10
is also present in the results achieved by fMRI. Furthermore, similar variability
was found within the somatosensory evoked potentials (SSEPs) derived from
a forepaw stimulation in a previous study were fMRI and EEG signals were
compared over weeks [112].
The nature of the anesthesia used in this study also plays a role in the
quality of the results achieved. The neurovascular coupling is very sensitive
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to anesthetics and sedatives [113–115] being reduced or suppress by many of
them [113,115,116]. In consequence, animals present variability on their response
to these substances and this inter individual variability may be exacerbated by
several factors such as the stress, the age, the amount of fat in relation to body
mass or the blood glucose among others.
Accordingly, by implementing the physiological conditions and therefore hav-
ing a better control of the anesthetized animal we might be able to find out under
which conditions the signal derived from the evoked functional activation can be
maximized. An open possibility is that there is an optimal temporal window for
measurement in terms of the physiological parameters under which the evoked
blood flow response might be maximized. The existence of this window has not
been confirmed yet and the features that characterizes it still remain unknown.
However I am currently investigating on this direction.
4.5 Conclusion
The evoked functional activation in rats can be measured with both the im-
planted ans the surface probe using this particular anesthesia protocol that
allows to proceed with longitudinal studies. The main advantage from the im-
plantable approach comes from the relatively low signal-to-noise ratio caused by
the absence of scalp and the accuracy in tracking the right regions of interest.
Also, it permits to proceed with optical and MRI measurements simultaneously.
However, its use involve exposing the animal to get infections after removing
the scalp and the natural animal growth might also be an issue because part of
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this probe is clamped into the rat skull. This fact suggest that the implantable
approach might be more convenient for longitudinal studies of short duration
(few weeks).
The surface probe eliminate this issues and permits to proceed with longer
longitudinal studies (a year duration or longer eventually). This opens the possi-
bility of studying chronic phases of neurodegenerative pathologies and possible
recovery therapies.
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5
Monitoring cerebral hemodynamics
during early hours after stroke
5.1 Introduction & motivation
Stroke is the loss of brain function provoked by the interruption of blood flow
supply in the brain which in the majority of cases is caused by an ischemia
although it can also be produced by an hemorrhage.
In the case of ischemic stroke (IS) a thrombus (blood clot), an arterial em-
bolus or a venous thrombosis partially or totally occlude a large cerebral artery
impeding the regular blood flow supply. This lack of blood flow can also be
produced by a cerebral hypoperfusion due to heart failure. In any case, the
consequences of this interruption can be dramatic as they easily lead to long
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term disabilities [117] or death.
Ischemic stroke is in fact one of the main causes of death [1, 2] in the West
and the long term disabilities derived from it have a huge impact in terms of
economical and human costs [118]. IS patients are often treated in specialized
stroke units where their brains are closely monitored.
The National Institutes of Health Stroke Scale (NIHSS) [119] is an extended
tool used to evaluate the impairment caused by stroke. This scale classifies the
stroke severity into asymptomatic (0), minor (1-4), moderate (5-15), moderate
to severe (16-20) and severe strokes (21-42). Neurologists also use the modified
Rankin Scale [120] to estimate the degree of disability or dependence after stroke.
This index ranges from 0 (no symptoms) to 6 (dead). In between, there are five
levels from which disability is classified as no significant (1), slight (2), moderate
(3), moderate-severe (4) and severe (5).
In order to reduce the damage derived from a IS, most of the medical inter-
ventions try to maximize the blood perfusion into the affected region. Some of
this strategies involve intravenous hydration or withholding anti-hypertensive
therapies. However, the blood perfusion depends on the cerebral perfusion pres-
sure (CPP) [121] which is defined as the difference between the mean arterial
pressure (MAP) and the intracranial pressure (ICP). Accordingly, another com-
mon medical practice to enhance the blood perfusion in IS patients is to lower
the head-of-bed or keep the patient flat.
A rapid restoration of the blow flow has been proved to reduce brain damage
[122] of IS patients. This fact makes timing to be also a key premise in most
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of these clinical interventions. In relation to this point, the use in thrombolysis
in the early hours after the stroke onset of recombinant tissue plasminogen
activator (rtPA) has been found to improve the functional outcome of ischemic
stroke patients [123].
Ischemic stroke patients are also classified depending on the time stage after
the stroke onset [124]. For instance, patients within the first 6 hours after the
stroke onset are referred as hyper-acute whereas the acute term is used in those
patients between 6 and 48 hours after the stroke onset. The subacute stage covers
a higher time period from the 48 hours up to 3 months and finally the chronic
one is used in those patients after 3 months after the stroke onset.
Transcranial doppler (TCD) is the primary clinical modality for bedside mon-
itoring of the cerebral hemodynamics in IS patients. However, TCD presents
some limitations as its use is restricted to large vessels [16]. Furthermore, inter-
preting TCD results can be difficult sometimes as it works under the assumption
that arteries keep a constant diameter [125]. In contrast, diffuse correlation
spectroscopy (DCS) allows non-invasive transcranial (through scalp, skull, etc..)
measurements of the cerebral hemodynamics [30–38].
The use of a head-of-bed (HOB) challenge alters the cerebral perfusion pres-
sure and therefore induces changes in the cerebral blood blow. TCD has been
used to monitor the effect of HOB challenge in the mean flow velocity (MFV) mea-
sured in occluded or partially recanalized middle cerebral artery (MCA) [126,127]
and it was found an increase in the MFV when lowering the HOB angle.
On the other hand, the use of HOB in combination with DCS has been used
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to study the cerebral hemodynamics in healthy patients and in scenarios where
the cerebral autoregulation is impared, such as ischemic stroke or brain injured
patients [33,37,38,77].
For instance, Edlow et al. [38] studied the hemodynamics of a cohort of
healthy subjects when lowering the HOB angle from 30◦ to 0◦ and estimated
the induced mean (standard error) cerebral blood flow (CBF) change in 18%
(±1.5%). Also, it was found that this change was independent from the age and
the gender of the subjects.
Some other studies used the same protocol to monitor ischemic stroke patients
during the acute stage. Thus, Durduran et al. [33] obtained a mean (standard
error) CBF change of 30% (±7%) and 25% (±7%) in the ipsi and contra-infarct
hemispheres when lowering the HOB angle from 30◦ to 0◦. In contrast, Favilla
et al. [77] estimated these changes in 17% (±4.6%) and 15% (±4.6%) in the ipsi
and contra-infarct side using again the same HOB change.
In these two studies, the mean CBF changes obtained presented heterogenous
distribution but this extended variability was not shown in healthy subjects [38]
and it might reflect underlying pathophysiology [77]. Also, both studies presented
a similar percentage (29%) of paradoxical responders (patients where the rCBF
decreases when lowering the HOB) among their populations. Interestingly, the
study carried out by Favilla et al. also included measurements of the MFV
obtained through TCD from which these paradoxical responders could not be
identified.
On the other hand, Kim et al. [37] used the same HOB protocol to study the
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hemodynamics of a group of 10 brain-injured patients (subarachnoid hemorrhage,
traumatic brain injury and arteriovenous malformation associated intracerebral
hemorrhage) during the acute stage versus a control group of 10 healthy subjects.
In compliance with the cohort of healthy subjects studied by Edlow et al. [38],
the control group presented a mean (standard error) CBF change of 18% (±0.9%)
when lowering the HOB angle from 30◦ to 0◦ whereas no change was found (0%
±2.8%) for the group of brain injured patients .
In this work I intend to take a step forward and to study the effect of a HOB
challenge (described later) in a group of ischemic stroke patients within the first
12 hours after the stroke onset and to relate this with a set of medical parameters.
The reason for focusing within this particular time stage was motivated by the
fact that some early measurements (<6 hours) were missing for some patients.
In order to facilitate the reading of this document, from now on I will refer as
hyper-acute to the time stage within the first 12 hours after the stroke onset.
This study was developed based on the following hypothesis:
• The change in the head-of-bed angle causes a significant change in the
rCBF for all the patients at all times and in both hemispheres.
• The change from 0◦ to 30◦ produces a decrease in the rCBF compared to
the initial supine position.
• The rCBF dependence on the HOB angle is correlated to the subjects
NIHSS at admission, 24 hours and at patient discharge.
• The rCBF dependence on the HOB angle is correlated to the modified
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Rankin Scale as continuous variable or binary index measured three months
after the stroke onset.
5.2 Methods
This study was performed in collaboration with Dr. Joan Mart´ı and Dr. Raquel
Delgado from the Stroke Unit of the Department of Neurology of Hospital de
la Santa Creu i Sant Pau. All the methods described in this section have been
approved by the Ethical Committee of Hospital de la Santa Creu i Sant Pau and
written consent forms were provided from each patient surrogate.
5.2.1 Demographics
A total of 21 ischemic stroke patients were monitored in three different time
stages as described in Table 6.1. The median of the age of the population was
of 85 years old with an interquantile range of 20.5 years. Since I am interested
in studying the blood flow response during the hyper-acute stage (<12 hours), I
have focused on the 22 (6+16) measurements carried out within this time stage.
<6 hours >6 hours & < 12 hours >12 hours
Measurements 6 16 20
Subjects 3 8 10
Table 5.1: Number of measurements and population before 6 hours, between 6
and 12 hours and after 12 hours after stroke onset.
The clinical status was evaluated in four time slots using the National In-
stitutes of Health Stroke Scale (NIHSS). The first evaluation was carried out
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when the patient arrived in the hospital, the second one was at 24 hours after
the stroke onset, the third one at 48 hours after the stroke onset and the last
one occurred at the patient discharge.
Most of the patients presented hypertension (90%) and half of them (48%)
also presented high values of dyslipidemia or cholesterol. The incidence of di-
abetes melitus was of 24% and only the 19% of the population were active
smokers. The 67% of the strokes occurred in the left brain hemisphere and a set
of clinical variables was also included in the study such as Thrombolisis which
is a categorical variable that indicates if the blocked artery has been recanalized
(successful treatment), if it has not (unsuccessful treatment) or if this information
is unknown.
Also, the condition of the Internal Carotid Artery (ICA) Stenosis was regis-
tered according to the following levels:
• 0 is referred to blockage of the ICA < 50% , meaning normal artery condi-
tion.
• 1 is referred to blockage of the ICA > 50% and < 70%.
• 2 is referred to blockage of the ICA > 70%.
• 3 is referred to the complete occlusion of the ICA.
• 4 the ICA condition is unknown.
Another binary variable produced by the clinicians and defined as Improve-
ment was included in the study. The criteria established by this variable states
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that a given patient has improved its condition if there is a reduction in the
NIHSS of 4 or more points 24h after the patient admission. The 24% of the
patients in this study have been considered to have improved their condition
according to this rule.
Finally, the modified Rankin Scale was also evaluated three months after the
stroke onset and included in this study.
5.2.2 Blood flow response to orthostatic challenge
I aimed to study the hemodynamics of this group of IS patients by monitoring
their blood flow response to the orthostatic challenge described in Figure 5.1.
The optical probe used on these experiments has already been described in detail
in Chapter 3.
The above mentioned challenge involved changing the HOB angle from an
initial supine position to 30◦ and to return back to supine. This process was
carried out on three time stages i.e 6 before hours, between 6 and 12 hours and
after 12 hours of the stroke onset. I note here that not all subjects were measured
at all three time points due to logistical reasons. The averaging time for each
single measurement was of 2 sec and the data was collected for 10 minutes on
each position.
The relative cerebral blood flow (rCBF) was obtained by normalizing the
blood flow index (BFI) with the initial supine position.
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Figure 5.1: Orthostatic challenge used with AIS patients
5.2.3 Statistical analysis
I have used the R-Project GNU General Public License software (http://www.r-
project.org) to build the statistical models. Thus, by fitting a linear mixed effects
(LME) models (library ”nlme” in R) [128], I explored the changes in the mean
rCBF as a function of two factors. The first factor was the HOB angle and
the second factor the remaining parameters described before. I used two-sided
models and Type I error rate of 0.05. The level of the confidence intervals shown
in the plots was of 95%.
5.3 Results
The CBF changes induced by the HOB challenge compared to the initial supine
position in the ipsi-infarct (ipsi) and contra-infarct (contra) hemispheres were
measured. The statistical analysis carried out with LME show no significant
relation between the administration of the rTPA treatment, Thrombolisis or the
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ICA Stenosis parameters and the blood flow response. With regards to the ICA
Stenosis, the majority of the patients had a blockage of the ICA lower than 50%
and therefore any dependence explored with this parameter lacks of statistical
meaning.
The rCBF change induced at 30◦ for both hemispheres versus time after
stroke (hours) is illustrated in Figure 5.2. The blue lines are fits to the data and
the grey regions show the confidence intervals.
In the top part of this figure we can see that there is no dependency (p=0.808)
between the rCBF and the time after stroke in the contra-infarct hemisphere.
However, DCS was sensitive enough to identify five paradoxical responders (23%
of total). The lower part of this plot shows the equivalent results found in the
ipsi-infarct hemisphere. In here, the number of measurements with paradoxical
response is up to six (27%) and there is a tendency (p=0.138) between the rCBF
induced at 30◦ and the time after the stroke onset.
Some tendencies were also found between the rCBF in the ipsi-infarct hemi-
sphere and the Improvement variable but we were not able to build any model
due to the lack of strength in the statistics, provoked by the low number of
patients who entered into this category (n=6). The high variability in the CBF
change versus two groups of improved and non improved patients is illustrated
in Figure 5.3. As we can see, the variable Improvement cannot be used as a
factor to distinguish between both groups (p=0.558).
Similarly, no statistical significant correlations but tendencies were found
when exploring the relation between the rCBF change and the NIHSS obtained
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Figure 5.2: CBF changes in contra-infarct (Top) and ipsi-infarct (Bottom) hemi-
spheres over time (hours after stroke onset) when head-of-bed position is in-
creased to 30◦. Both hemisphere present a similar percentage of paradoxical
responders (23% and 27% respectively). There is no dependence on time after
stroke in the contra-infarct hemisphere (p=0.808) where there is a the tendency
(p=0.138) in the ipsi-infarct one. Blue lines are linear fits to the data and dark
gray region are showing the confidence intervals.
at different time stages i.e (patient admission, 24 and 48 hours after the patient
admission). This is illustrated in Figure 5.4 where we can see how the majority
of the patients at hospital admission present a NIHSS index higher than 15. Due
to the medical treatment, 24 hours later the NIHSS index gets reduced in some
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Figure 5.3: Boxplot of CBF changes at 30◦ in the ipsi-infarct (ipsi) hemisphere
versus the Improvement parameter.
patients and it shows a more homogeneous distribution being this distribution
very similar when obtained 48 hours after the patient admission. In these last
two representations (middle and right plots of Figure 5.4) some trends (p=0.267;
p=0.219) can be observed suggesting that patients with lower NIHSS have a
higher (negative) CBF change in the ipsi-infarct hemisphere when moving the
HOB from supine to 30 degrees.
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Figure 5.4: Left: CBF changes at 30◦ in the ipsi-infarct (ipsi) hemisphere versus
NIHSS measured at the patient admission in hospital. Middle: CBF changes at
30◦ in the ipsi-infarct (ipsi) hemisphere versus NIHSS measured 24h after the
patient admission.Right: CBF changes at 30◦ in the ipsi-infarct (ipsi) hemisphere
versus NIHSS measured 48h after the patient admission. In all the plots,the blue
line is the linear fit to the data and the dark gray region shows the confidence
interval.
The NIHSS was also registered at the patient discharge. The rCBF change
induced at 30◦ in the ipsi-infarct hemisphere versus three groups of NIHSS-
based patients is represented in Figure 5.5. The first two groups were clustered
according to lower/higher NIHSS than 10. The third one represented with the
character x is related to those patients (n=4) who unfortunately passed away.
Although this plot lacks of statistical significance, is interesting to see that three
of the deceased patients did not shown any response to the HOB change and the
Monitoring cerebral hemodynamics during early hours after stroke 82
last one presented the strongest paradoxical response among the total population.
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Figure 5.5: Boxplot of CBF changes at 30◦ in the ipsi-infarct (ipsi) hemisphere
versus the NIHSS at discharge clustered in three groups. The first group contains
the patients with NIHSS<10 whereas the second one is related to patients with
NIHSS>10. The third one (”x”) is related to deceased patients who did not
survive. The patients within this group either did not show any response to the
HOB change induced or they present the strongest paradoxical response.
On the other hand, statistical significant models were produced when explor-
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ing the relation between the rCBF response to the orthostatic challenge during
the hyper-acute stage versus the Rankin Scale obtained 3 moths after the stroke
onset. The left plot of Figure 5.6 illustrates this change induced in the ipsi-infarct
hemisphere at 30◦ versus the modified Rankin Scale as a continuous variable
(p=0.012).
It can be seen that patients who present a higher change in the rCBF at 30◦
(negative values) during the hyper-acute stage also have better output (lower
values of the modified Rankin Scale). The right plot of Figure 5.6 illustrates
the same changes but considering the modified Rankin Scale as a binary index
(p=0.002). As we can see, the paradoxical responders appear when the modified
Rankin Scale is higher than 2. As before, patients who had a higher (negative)
change in the ipsi-infarct hemisphere at 30◦ also presented a better output
(modified Rankin Scale <=2) in contrast to the group of patients with modified
Rankin Scale >2.
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Figure 5.6: Left: CBF changes at 30◦ in the ipsi-infarct (ipsi) hemisphere versus
Rankin Index as a continuous variable. The blue line is the linear fit to the data
(p=0.012) and the dark gray region shows the confidence interval. Right: CBF
changes at 30◦ in the ipsi-infarct (ipsi) hemisphere versus Rankin Index as a
binary index (p=0.002).
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5.4 Discussion
In this study, It was confirmed that the change in the head-of-bed has a significant
effect on the rCBF response of ischemic stroke patients. The rCBF change
compared to baseline values decreased in most of the patients when increased the
HOB angle to 30◦. However, in 24% of the measurements we found paradoxical
responses in the contra-infarct hemisphere versus a 28% when considering the
ipsi-infarct hemisphere. In any case, both percentages are in compliance with
similar studies where the population of paradoxical responders was about 29%
[33,77].
I have explored the relation of the rCBF with many variables using linear
mixed efffects (LME) models. No statistical findings revealed a dependence be-
tween the rCBF changes and the use of recombinant tissue plasminogen activator
(rTPA) and the Thrombolisis and ICA Stenosis parameters. In this regards, the
low number of patients which show reperfusion upon successful thrombolisis in
large vessels might not be enough to find any dependence in the microvasculature.
Similarly, since the majority of patients had a blockage of the ICA lower than
50%, any dependence explored with this parameter lacks of statistical meaning.
On the other hand, the results obtained when exploring the dependence
between the rCBF induced at 30◦ measured in the ipsi-infarct hemisphere and the
time after the stroke onset suggest some improvement in the cerebral vasculature
in some patients which is reflected in the rCBF increase (negative values) with
the time after the stroke onset.
Some tendencies were found between the rCBF in the ipsi-infarct hemisphere
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and the Improvement variable (which is based on the NIHSS) for the 0◦ to
30◦ but we were not able to build any model due to the lack of strength in
the statistics. Similarly, some other tendencies were found when exploring the
relation between the rCBF induced at 30◦ and the NIHSS obtained at 24 and 48
hours after the stroke onset. This relation did not apply when considering the
NIHSS values obtained at the patient admission as most of the NIHSS values
are located around the same area (>15). Moreover, when exploring this relation
at the patient discharge, no statistical significant results were obtained either.
However, it was found that the small group of deceased patients did not show
any blood flow response to the orthostatic challenge but one patient who show a
strong paradoxical response. This finding seems to be related to the impairment
of the cerebral hemodynamics on these patients and it is in compliance with
previous results found in brain-injured patients [37] .
Finally, a statistical significant dependence was found between the CBF
changes at 30◦ and the modified Rankin Scale measured three moths after the
stroke onset. In this regards, the fact of have found statistical significant depen-
dence using a functional scale (modified Rankin Scale) versus some tendencies
when using instead a stroke scale (NIHSS) could be related to the fact that
stroke scales only partly explain functional health [129]. This results suggest
that by studying the hemodynamic response of ischemic stroke patients in the
early hours after the stroke onset, we might be able to predict the patient output
according to the modified Rankin Scale three months after the stroke onset.
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5.5 Conclusion
The measurement of the rCBF response to an orthostatic challenge in the early
hours after the stroke onset has reveal to provide promising information that can
be used to predict the outcome of patients according to the functional modified
Rankin Scale. DCS has proved again its capability in identifying paradoxical
responders which might open the gate to ad hoc treatments by simply using the
HOB in terms of maximizing the blood flow reperfusion into the infarcted area.
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6
Cerebral hemodynamics of Obstructive
Sleep Apnoea patients in response to
orthostatic challenge
6.1 Introduction & motivation
The obstructive sleep apnoea (OSA) syndrome is characterized by the presence
of total (apnoeas) or partial (hypopnoeas) collapse of the upper airway during
sleep that affects 2-4% of the general population [130]. OSA syndrome symptoms
include snoring, daytime sleepiness, morning headache, sexual dysfunction, mood
and behavioral disorders, increased rate of traffic and occupational accidents
and impaired quality of life [131]. The combination of these factors produce
considerable economical costs which account for millions of dollars per year [132].
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Each apnoea or hypopnoea event produce an episode of hypoxia-reoxygenation,
increased autonomic activity and changes in intrapleural pressure. These mecha-
nisms promote atherogenesis by different pathogenic pathways as oxidative stress,
endothelial dysfunction [133,134], hypercoagulability and metabolic disorder as
insulin resistance [135].
These multi factorial processes are involved as pathogenic factors in the
development to OSA syndrome as a cardiovascular risk factor with increased
cardiovascular morbidity [136] such as hypertension, ischemic heart disease,
stroke [7, 8, 137], arrhythmia, chronic heart failure and cardiovascular mortality
especially in middle-aged population [11, 138–140]. OSA syndrome treatments
cover medication, oral appliances and surgery among some other methods. How-
ever, the application of a continuous positive airway pressure (CPAP) therapy
is of great use in improving the condition of OSA patients [141].
The diagnosis of this sleep disorder is performed by a sleep study (polysomnog-
raphy or respiratory polygraphy). Among all the information derived from this
type of study, there are a set of key parameters from which physiologists obtained
the most important information in terms of diagnosing OSA syndrome (A full
set of acronyms are included at the end of this chapter). They are basically the
following:
• The Mean Arterial Oxygen Saturation, which is the mean value of SpO2
over the night sleep.
• The Minimum Arterial Oxygen Saturation, which is the minimum value
of SpO2 over the night sleep.
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• CT90 which is defined as the percentage of time during the study where
the SpO2 was lower than 90%.
• ODI4%, the oxygen desaturation index at 4%. It is defined as the number
of times per hour where the values registered for SpO2 decrease 4% due to
an apnoea.
In addition, the Epworth Sleepiness Scale [142] is an external parameter that
can be helpful in diagnosing sleep disorders and basically consist in measuring
the daytime sleepiness by using a questionnaire which is filled by the patient.
The severity of this syndrome is defined by the Apnoea-Hypopnoea Index
(AHI) (number of apnoea and hypopnoeas events/sleep hour) from which OSA
patients are classified as Severes (AHI≥30), Moderates (15≤AHI<30) and Milds
(5≤AHI<15). Patients with AHI<5 are considered as Healthy subjects or Non-
OSA. Within this contex, the presence of an AHI>15 is associated with increased
cardiovascular risk, with or without associated symptoms, and this risk is much
higher for patients with an AHI>30 [143].
One of the hypotheses associated to the increased risk of strokes in OSA
patients is related to impairments or alterations of cerebrovascular reactivity
(CVR) [144] or cerebral autoregulation (CA) [10]. Cerebral vascular reactivity is
an index of the capacity of the cerebral vessels to adapt to the metabolic demands
of the brain and an autoregulation system to maintain a relatively constant
blood flow during fluctuations in its perfusion pressure [145]. Since OSA patients
present decreased cerebral autoregulation, they would have a lower compensating
cerebral blood flow response to changes in pressure and this impairment of
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cerebral autoregulation likely contributes to the increased incidence of stroke, as
well as the poor outcome after stroke [12,13].
Diffuse correlation spectroscopy (DCS) has been used to study the cerebral
hemodynamics in humans [30–38]. In this regards, when studying of the cerebral
autoregulation it is quite common to provoke a controlled change in the cerebral
perfusion pressure to induce a change in the cerebral blood flow (CBF). For
instance, the CBF response to bilateral thigh pressure cuff inflation/deflation
protocol has been studied with DCS [36] and it was found that OSA patients
present a significantly lower decrease in the CBF (−17%) when compared to a
healthy control group (−26%).
Another common option to study the cerebral hemodynamics comes from
the use of a head-of-bed (HOB) challenge. In this context, transcranial doppler
(TCD) has been used to monitor the effect of HOB challenge in the mean flow
velocity (MFV) [125–127,146] but this technology presents some limitations as
its use is restricted to large vessels [16] and the results derived from it must be
interpreted carefully because TCD works under the assumption that arteries
keep a constant diameter [125]. In contrast, DCS permits to study the cerebral
microvasculature through a non-invasive transcranial (through scalp, skull, etc..)
approach. The cerebral hemodynamics derived from a HOB challenge have been
studied with DCS in both a cohort of healthy subjects [38] and different groups
of patients with impaired cerebral autoregulation caused by neurological diseases
such as ichemic stroke or brain-injured [33,37,77].
In these studies [33,37,77], measurements were initiated with the patient sit
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at 30◦ angle and the change in the cerebral blood flow according to this initial
position was obtained when lowering the HOB angle from 30◦ to 0◦ (supine
position).
The mean (standard error) relative cerebral blood flow for the above men-
tioned HOB change was estimated in 18% (±1.5%) for the cohort of healthy
subjects [38] and it was also found to be age and gender independent. It contrast,
when studying ischemic stroke patients, Durduran et al. [33] obtained a mean
(standard error) CBF change of 30% (±7%) and 25% (±7%) in the ipsi- and
contra-infarct hemispheres whereas Favilla et al. [77] estimated these changes
in 17% (±4.6%) and 15% (±4.6%) in the ipsi- and contra-infarct respectively.
The heterogeneous distribution in the CBF change present in these last two
studies is suggested that might reflect underlying pathophysiology [77] in con-
trast to the study of healthy subjects [38] where this extended variability was
not shown. Furthermore, both cohorts of ischemic stroke patients had similar
percentages (around 29%) of paradoxical responders (patients where the rCBF
decreases when lowering the HOB or the other way around) being those patients
undetectable through TCD measurements [77].
Kim et al. [37] also compared the hemodynamic responses of one group
of 10 brain-injured patients (subarachnoid hemorrhage, traumatic brain injury
and arteriovenous malformation associated intracerebral hemorrhage) versus a
control group of 10 healthy subjects using the same HOB protocol. No change
was found (0% ±2.8%) for the group of brain injured patients whereas the control
group presented a mean (standard error) CBF change of 18% (±0.9%) being
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this results in compliance with the cohort of healthy subjects studied by Edlow
et al. [38].
Since OSA patients might present impaired cerebral autoregulation, I intend
to study the hemodynamic response to an orthosthatic challenge of a group
of OSA patients and to compare their cerebral hemodynamics with a control
group of healthy subjects. Furthermore, this study was developed to explore if
AHI-based groups of OSA patients show different cerebral blood flow responses
and to find out if the CVR may correlate with key respiratory parameters.
Thus, the objectives of this study can be summarized as follows:
• To explore if AHI based groups of OSA patients show different responses
to an orthostatic stress test.
• To study the CA of the OSA patients versus the Non-OSA along the
orthostatic challenge.
• To study possible correlations between the blood flow responses and a set
of respiratory parameters.
On the other hand, the oxy- and deoxy-hemoglobin concentrations were also
obtained during the orthostatic test -hence the design of the probe described in
Chapter 3- but this part of the study is still in preparation. Furthermore, this
study was part of a more extended project on which the hemodynamics of the
severe OSA patients were studied during a Splitted Night where patients sleep
half of the night without any treatment whilst a CPAP treatment is applied
in the second part. This is the reason why the optical probe had to be CPAP
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compatible. This study (also in preparation) consisted in a polysomnography
(PSG) in combination with blood flow measurements obtained with DCS carried
out to monitor how effective the CPAP treatment was in OSA patients.
As an overall, these studies also give us the opportunity to explore the
feasibility of DCS as a diagnostic tool in a cohort of patients which might have
different levels of impaired cerebral autoregulation.
6.2 Methods
This study was performed in collaboration with MD. Mercedes Mayo, MD. Ana
Fortuna and Dr. Anna Mola from the Sleep Unit of the Department of Respira-
tory Medicine of Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. All the
methods described in this section have been approved by the Ethical Committee
of Hospital de la Santa Creu i Sant Pau and written consent forms were provided
from each patient. The OSA patients enrolled in this study were derived from
the Sleep Unit after successfully passing through an exclusion criteria which
covered the following points:
• Patients older than 80 years old.
• Patients which received a previous CPAP treatment.
• Patient with chronic obstructive pulmonary disease (COPD)
• Patients with neuromuscular diseases.
• Patients with previous Ischemic Stroke.
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• Patient who refuse to participate in the study.
6.2.1 Sample size and demographics
A cohort of 83 patients (63.9% Males) conformed the population of this study.
Table 6.1 reflects the distribution of patients according to the AHI classification.
Non-OSA Mild Moderate Severe
Population 14 (16.9%) 29 (34.9%) 12 (14.5%) 28 (33.7%)
Table 6.1: Number and percentage of patients splitted by AHI group
Some patients presented hypertension (24%), dyslipidemia or cholesterol
(18%) and diabetes melitus (14%). The 51.5% of the population were conformed
by non-smokers whilst the 33% and 15.5% of them were former and active smok-
ers. The body mass index (BMI) showed a distribution 36.1% of overweighted
(25≤BMI<29.99) and 24.1%, 9.6% and 7.2% of obese mild (30≤BMI<34.99),
obese moderate (35≤BMI<39.99) and obese morbid (BMI≥40) patients respec-
tively.
The 3.6% of the patients (n=3) presented asthma and one subject had a
previous transient ischemic attack (TIA). The remaining patients did not present
other respiratory or neuro pathology ( chronic obstructive pulmonary disease,
ischemic stroke and others diseases). Cardiopathologies (coronary artery disease
(CAD), heart failure (HF) and other diseases) were not relevant on 95.2% of the
population.
The median and interquantile range (IQR) was obtained for the BMI, AHI,
age and Epworth Sleepiness Scale as shown in Table 6.2. A similar description
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related to the respiratory variables can be found on Table 6.3 which shows how
the severe group is affected by parameters such as the CT90 (16.2% of the time
with SpO2 lower than 90% during sleep) or the ODI4% (63.5 occurrences where
SpO2 drops 4% due to an apnoea per hour sleep). These values are reduced for
the remaining groups. Thus, the moderate group presents a 1.4% for the CT90
and 15.2 occurrences for the ODI4% whereas the mild group has a 0% for the
CT90 and 5.7 occurrences for the ODI%. Finally, the control group of Non-OSA
patients presents a 0% for the CT90 and 1 occurrence for the ODI%.
Total Severe Moderate Mild Non-OSA
BMI (Kg/m2) 28.5 (8) 32.6 (5.6) 26 (4.4) 28.2 (7.1) 23.5 (3.5)
AHI (Apnoeas/hour) 14.3 (39.8) 73.5 (37.9) 19 (2) 9.4 (4.9) 2 (2.9)
Age (Years) 54 (13.5) 58 (10.2) 52.5 (14.2) 54 (12) 52.5 (15.5)
Epworth (a.u.) 10 (8) 11.5 (7.2) 10 (7) 12 (7) 7 (4)
Table 6.2: Demographics of patients (median and IQR in brackets) splitted by
AHI group
Total Severe Moderate Mild Non-OSA
Mean SpO2 (%) 94 (3) 93 (3) 95 (2) 95 (2) 95.5 (1)
Min SpO2 (%) 86 (13) 76 (10.5) 84 (8) 88 (5) 91.5 (3)
CT90 (%) 0.4 (10.6) 16.2 (16.7) 1.4 (3.1) 0 (0.3) 0 (0)
ODI4% (occurrences) 11.1 (38.1) 63.5 (32.6) 15.2 (9.7) 5.7 (6.9) 1 (2.4)
Table 6.3: Respiratory parameters of patients (median and IQR in brackets)
splitted by AHI group
6.2.2 Blood flow response to orthostatic challenge
In this study I have utilized a modified version of the orthostatic challenge
used to monitor the hemodynamics of acute ischemic stroke patients [33, 77].
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This protocol involved changing the head-of-bed (HOB) angle in the following
sequence: 0◦ to 30◦ to 0◦ to 20◦ to −8◦ to 0◦. The angle corresponding to 30◦
involves tilting only the back of the bed while the 20◦ tilts the whole bed as
illustrated Figure 6.1.
0◦ 30◦ 
(5 min) (5 min) (5 min) (5 min) (5 min) (5 min) 
0◦ 20◦ -8◦ 0◦ 
Figure 6.1: Diagram of the orthostatic challenge employed in this study.
In order to initiate the experiment with stable CBF values, patients remained
in a comfortable supine position for 15 minutes prior to start the measurement.
During the experiment, patients stayed for 5 minutes at each HOB position.
The relative cerebral blood flow (rCBF) was obtained by normalizing the
blood flow index (BFI) obtained for each HOB angle with the mean BFI corre-
sponding to the initial supine position.
I was also interested in exploring the absolute change in the CBF any time I
move the patient along the orthostatic challenge by looking at a new parameter
called Self Normalized rCBF (SNORM rCBF) by normalizing all the BFI values
for a given angle with the mean BFI value that corresponds to the previous
HOB position.
In both cases, the rCBF and the SNORM rCBF were averaged for each HOB
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stretch but the values obtained during the initial and the last minute on each
HOB position were discarded to avoid transient effects. In consequence both
parameters presented a unique mean value per HOB angle.
In some occasions patients sneezed or coughed accidentally provoking alter-
ations in the BFI measurements. A filtering process was therefore applied to
get rid of any value of the rCBF or the SNORM rCBF higher than twice the
standard deviation on each averaging stretch.
I also monitored the mean arterial pressure (MAP), the arterial oxygen
saturation by pulse oximetry (SpO2) and the heart rate (HR) in 25 patients at
each head of bed position. The MAP was registered in the middle of each HOB
position whilst the SpO2 and HR were measured one minute after locating the
patient on a given position and one minute prior to change it and then both
values were averaged.
6.2.3 Adapted Instrumentation
I have utilized a portable set-up described in Chapter 3. I note that I have used
a probe designed for a sleep study in a subset of the population since we desire
the ability to compare the results. The hybrid probe developed had to be located
over the patient’s forehead as shown on Figure 6.2 in a manner that was not
affected by the movement of the patient and allowing to place some other sensors
like electrodes, microphones or any medical hardware related to the use of a
polysomnography.
Also, the probe had to allow the implant/removal of a continuous positive
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Detail of the “Suspension Bridge” 
system 
DCS Probe 
ISS Imagent 
Probe 
CPAP Anchoring 
Clamp 
Figure 6.2: Overview of the hybrid probe on the patient’s forehead during a
polysomnography.
air pressure (CPAP) mask when necessary with the minimum impact possible
on the optical measurement. This problem was solved by utilizing the straps of
the CPAP mask on an adjusting system based on the forces developed on the
structure of a suspension bridge. The key part of the system were two metallic
pieces shown in bottom right side of Figure 6.2. The system worked in a way
that the stronger the CPAP straps were tighten up, the stronger the probe was
attached, adapting its form to the shape of the patient forehead.
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6.2.4 Statistical analysis
As in chapter 5, I have used the R-Project GNU General Public License software
(http://www.r-project.org) to build two types of statistical models. In the first
one, by fitting a linear mixed effects (LME) models (library ”nlme” in R) [128], I
explored the changes in the mean rCBF and mean SNORM rCBF as a function
of two factors. The first factor was the HOB angle and the second factor the
remaining clinical and respiratory parameters. On the second type, I proceed in
the same way but focusing on the 0◦ to 30◦ change and therefore excluding the
HOB angle as a factor from the models. In both cases, I used two-sided models
and Type I error rate of 0.05. The level of the confidence intervals shown in the
plots was of 95%. Also, Pearson product-moment correlation coefficients were
obtained to explore linear correlations between two variables and paired T-Test
were used to determine if two sets of data were significantly different from each
other.
6.3 Results
6.3.1 Mean arterial pressure, arterial oxygen saturation
and heart rate during the orthostatic challenge
The results obtained for the mean arterial pressure (MAP), the arterial oxygen
saturation (SpO2) and the heart rate (HR) for all the HOB angles can be
visualized on Figure 6.3. A paired T-Test was carried out to find out if changes
on the MAP, SpO2 and HR along the orthostatic challenge were statistically
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different from the first supine position. As it can be seen on Table 6.4, MAP
has a statistically significant change when the head is elevated at 30◦ and 20◦
respect to the initial supine position whereas the SpO2 has the same significance
at 30◦ only (although the pvalue corresponding at 20◦ is quite close to 0.05).
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Figure 6.3: Top: Distribution of the mean arterial pressure (MAP) values at
each HOB angle. Middle:Distribution of the arterial oxygen saturation (SpO2)
values at each HOB angle. Bottom: Distribution of the heart rate (HR) values
at each HOB angle.
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∆MAP (mmHg) ∆SpO2 (%) ∆HR (bpm)
Supine 1 vs 30◦ -5.30 (< 0.001*) -0.54 (0.006*) -0.74 (0.396)
Supine 1 vs Supine 2 -1.08 (0.089) -0.04 (0.863) 0.88 (0.230)
Supine 1 vs 20◦ -3.26 (< 0.001*) -0.42 (0.054) -0.06 (0.948)
Supine 1 vs −8◦ -0.52 (0.495) 0.3 (0.181) 1.18 (0.206)
Supine 1 vs Supine 3 -1.16 (0.273) -0.042 (0.129) 0.4 (0.735)
Table 6.4: Changes (pvalues) in the mean arterial pressure (MAP), the arterial
oxygen saturation (SpO2) and the heart rate (HR) of 25 patients when comparing
HOB angles. The MAP has a statistically significant change when the head is
elevated at 30◦ and 20◦ respect to the initial supine position whereas the SpO2
has the same significance at 30◦ only (although the pvalue corresponding at
20◦ is quite close to 0.05). Both parameters do not change significantly when
patients are put back in supine positions or at −8◦. The heart rate does not
change significantly along the orthostatic test when compare to the initial supine
position
As expected, both parameters do not change significantly when patients
are put back in supine positions or at −8◦. Finally, the heart rate does not
change significantly along the orthostatic test when compare to the initial supine
position.
6.3.2 Blood flow response along the orthostatic challenge
The results obtained per group and HOB angle for the rCBF and SNORM rCBF
are contained on Tables 6.5-6.6.
These results show homogeneity among the blood flow responses of all the
groups at the initial 0◦ to 30◦ change. However, this homogeneity is broken for
the remaining HOB angles. This is illustrated in Figure 6.4. As we can see, the
CBF response is similar for the groups in the initial HOB change. After that,
the blood flow response for the OSA groups clearly diverge when compared to
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TOTAL SEVERE MODERATE MILD NON-OSA
0◦ to 30◦ -17.1 (1.1) -16.2 (2) -17.7 (2.3) -17.5 (1.8) -17.3 (2.7)
30◦ to 0◦ 4.5 (1.4) 7.5 (2.5) 8.1 (3.6) 4.4 (2.5) -4.4 (2.5)
0◦ to 20◦ -10.2 (1.7) -6.1 (3) -9.3 (4) -11.6 (2.5) -16.5 (4.5)
20◦ to −8◦ 14.9 (2.2) 17.5 (3.7) 21.3 (4.5) 17.4 (4.1) -0.7 (4.5)
−8◦ to 0◦ 11.2 (2.1) 16 (3.7) 19.1 (4.8) 11.5 (3.2) -5.6 (4.3)
Table 6.5: rCBF values (in %): Mean and Standard Error of the Mean (SEM) per
patient type and HOB angle. The mean blood flow responses of all the groups
at the initial 0◦ to 30◦ change presents homogeneous values (-17.1%, -16.2%,
-17.7%, -17.5% and -17.3%). This homogeneity is broken for the remaining HOB
changes.
TOTAL SEVERE MODERATE MILD NON-OSA
0◦ to 30◦ -17.1 (1.1) -16.2 (2) -17.7 (2.3) -17.5 (1.8) -17.3 (2.7)
30◦ to 0◦ 27 (2) 29.6 (3.6) 31.3 (2.3) 27.9 (3.9) 16.4 (2.9)
0◦ to 20◦ -14.1 (1.1) -12.8 (1.6) -16.3 (2) -15 (1.9) -12.8 (4)
20◦ to −8◦ 29.1 (1.9) 26.5 (3.3) 34.7 (3.2) 33.5 (3.3) 20.4 (4.1)
−8◦ to 0◦ -3 (0.7) -1.2 (1.2) -1.9 (1.5) -4.4 (1.4) -4.9 (0.9)
Table 6.6: Self-Normalized rCBF values (in %): Mean and Standard Error of
the Mean (SEM) per patient type and HOB angle. The absolute change in the
blood flow response present similar range within the first HOB change. After
that, the SNORM rCBF values starts diverging, particularly when comparing
the OSA versus the Non-OSA populations.
the control group of healthy subjects. For instance, when we look at the second
and third supine positions we can see how distribution of rCBF values is mostly
located in the positive Y axis. In contrast, the distribution obtained for the
healthy control group is closer to zero and most of its distribution is located in
the negative Y axis.
This effect is more clear when looking at the absolute CBF change (SNORM
rCBF) versus the reordered HOB angles going from positive to negative angles.
This is illustrated in Figure 6.5. As we can see, changes of similar magnitude in
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Figure 6.4: Distribution of the blood flow responses per group obtained along
the orthostatic challenge when normalized with the initial supine position. The
initial 0◦ to 30◦ change induce a similar response in all the groups. Right after,
the blood flow responses for the OSA groups clearly diverge when compared to
the control group of healthy subjects.
the HOB (30◦,−30◦ and −28◦) seem to produce different blood flow responses
for the different groups. Thus, the blood flow change in absolute value for the
OSA groups seems to be higher at −30◦ and −28◦ when compared to the 30◦
change. In contrast, the flow response obtained for the control group at −30◦
and −28◦ seems to be in compliance with the initial change of 30◦.
The results obtained in Table 6.7 confirmed that these changes at −30◦ and
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Figure 6.5: Self-Normalized rCBF boxplot for all different groups versus HOB
angles. Changes of similar magnitude in the HOB (30◦,−30◦ and −28◦) produce
different blood flow responses for the OSA and Non-OSA groups. These changes
are higher for the OSA groups at −30◦ and −28◦ when compared to the 30◦
change. In contrast, the flow response obtained for the control group at −30◦
and −28◦ is in compliance with the initial change of 30◦.
−28◦ were statistically different than the initial change induced at 30◦ for all the
OSA groups. In contrast, these changes were the same for the control group of
healthy subjects.
The increase in the Self-Normalized rCBF when moving along the HOB
angles axis for all the OSA groups illustrated previously on Figure 6.5 have
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30◦ vs −30◦ 30◦ vs −28◦ −30◦ vs −28◦
Total < 0.001* < 0.001* 0.286
Severe < 0.001* 0.001* 0.405
Moderate 0.003* < 0.001* 0.355
Mild 0.003* < 0.001* 0.133
Non-OSA 0.704 0.414 0.192
Table 6.7: T-test pvalues comparing the Self-Normalized rCBF for the HOB
angles at 30◦,−30◦ and −28◦. In the OSA groups, the changes induced at −30◦
and −28◦ are statistically different than the initial change induced at 30◦. In
contrast, these changes are the same for the control group of healthy subjects.
encouraged us to explore if there is any dependence between that increase and
the HOB angle that might be correlated with all the parameters and groups
involved on this study.
For that purpose, I have produced a linear fitting with the Self-Normalized
rCBF per patient versus the ordered HOB angles and added the slope of these
fitting as a new parameter called Slope. This concept is illustrated in Figure 6.6.
The top part of this graph shows the boxplot values for the Self-Normalized
rCBF versus the ordered HOB angles whereas the bottom part illustrates the
concept of the Slope by showing some linear fittings for all the groups of patients.
6.3.3 Exploring the dependence of the blood flow response
on the clinical and respiratory parameters
I have initially explored any possible dependence between the rCBF and the
remaining parameters by using Pearson’s correlation coefficient tests. Several
models were created by exploring the dataset as a global and also by clustering
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Figure 6.6: Top: Self-Normalized rCBF boxplots versus the ordered HOB angles.
Bottom: Example of slopes produced when fitting the Self-Normalized rCBF
versus the HOB angles.
it according to the patient AHI-based groups or the HOB change applied but
no relation was found on these initial tests.
A more sophisticated approach was carried out through linear mixed effects
(LME) models and the following relations were found:
• There is a statistically significant dependence (p<0.001) of the rCBF with
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the HOB angle as fixed effect when no classification is applied to the
patients in terms of the Apnoea-Hypopnoea Index (Severe, Moderate, Milds
and Non-OSA) i.e considering all the groups as one.
• The previous relation breaks (p=0.074) when the group classification of
patients based on the Apnoea-Hypopnoea Index is included. This finding
reveals that although there is a clear effect of the flow response provoked by
the HOB changes, we cannot distinguish this effect among the AHI-based
groups.
• There is a statistically significant dependence (p=0.002) between rCBF
and the HOB angle in addition to the Mean Oxygen saturation as fixed
effects.
• There is a statistically significant dependence (p=0.001) between rCBF
and the HOB angle in addition to the Body Mass Index as fixed effects.
6.3.3.1 Mean Oxygen Saturation and Body Mass Index
As previously mentioned, I have researched through LME the effect in the blood
flow response of the HOB change in addition to the mean oxygen saturation on
one side and the Body Mass Index on the other side as fixed effects. Statistically
significant dependencies were found for these two model produced, when consid-
ering all the groups together along the orthostatic test. This relation implies that
rCBF decreases whenever the Mean Oxygen Saturation increases as illustrated
in Figure 6.7.
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Figure 6.7: rCBF versus Mean Oxygen Saturation for all the HOB angles and
all the groups. The blue area represents the confidence intervals for the model
whereas the pink one covers the area ± twice the standard deviation.
As we can see, the flow response is higher in the 0◦ to 30◦ change for those
patients who present better (higher) values in the mean oxygen saturation in
contrast to the low flow response for those subjects who present worst (lower)
values in the mean oxygen saturation. When looking at the 30◦ to 0◦ instead,
the patients with better values of mean oxygen saturation seem to recover easier
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to baseline. However, as we move along the orthostatic test, the rCBF values
diverge and interpretation of any trend must be done with caution.
This dependency was also found when considering only the Mild group as
illustrated in Figure 6.8.
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Figure 6.8: rCBF versus Mean Oxygen Saturation for all the HOB angles and
Mild group. The blue area represents the confidence intervals for the model
whereas the pink one covers the area ± twice the standard deviation.
As before, patients who have better levels of the mean oxygen saturation
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seem to perform better.
A similar type of dependency appears with the rCBF and HOB angle plus
the Body Mass Index when considering again all the groups together along the
orthostatic test. This is illustrated in Figure 6.9 where we can see how the rCBF
decreases whenever the Body Mass Index increases in the 0◦ to 30◦ change.
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Figure 6.9: rCBF versus BMI for all the HOB angles and all the groups. The
blue area represents the confidence intervals for the model whereas the pink one
covers the area ± twice the standard deviation.
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This dependency also stands for the Mild group as shown in Figure 6.10. As
with the previous example, the rCBF values diverge whenever we move along
the orthostatic test and the interpretation of trends must be done carefully.
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Figure 6.10: rCBF versus BMI for all the HOB angles and Mild group. The
blue area represents the confidence intervals for the model whereas the pink one
covers the area ± twice the standard deviation.
In relation to these last two LME models, the blood flow response is lower
in patients who present poorer values of the Mean SpO2 in the 0
◦ to 30◦, 30◦
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to 0◦ and 0◦ to 20◦ changes. A similar relation (but opposite tendency) applies
to those patients with higher BMI where their flow response is also lower for
those changes. In both models, the further HOB changes are more variable and
therefore interpretation becomes more difficult. In this regards, we must take
into account the short range of both Mean SpO2 and BMI variables that weakens
the strength of the models.
6.3.4 Exploring the rCBF at the 0◦ to 30◦ HOB change
The rCBF presents a more homogeneous distribution in the at 0◦ to 30◦ change
and therefore I have focused on this HOB change to explore its dependence (if
any) with a set of fixed key factors: The AHI, the Mean SpO2, the CT90, the
ODI4% and the BMI. The population of paradoxical responders (patients where
the rCBF increases when changing the HOB from 0◦ to 30◦) was very low (4.8%)
in contrast to previous studies carried out with ischemic stroke patients [33, 77]
where this population was quite significant (around 29%). Since the reverse effect
in the blood flow response of the paradoxical responders is quite strong, I have
followed the criteria used by Favilla et. al [77] to avoid confounding effects and
excluded these patients from the statistical analysis.
The results of these models can be checked on table 6.8.
The NA text remarks the prior discussed point of the low range of the
parameters involved. This restriction particularly applies to the Non-OSA, Mild
and Moderate groups. As consequence, I have focused the modeling on the Severe
group and all the groups together (Total).
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Non-OSA Mild Moderate Severe Total
AHI NA NA NA 0.123 0.571
Mean SpO2 NA NA NA 0.091 0.26
CT90 NA NA NA 0.291 0.418
ODI4% NA NA NA 0.265 0.873
BMI NA NA NA 0.606 0.219
Table 6.8: P-Values for LME with rCBF as a fixed factor. NA=Not Applicable
In these results, no statistical significant dependences were found between
the rCBF produced for the 0◦ to 30◦ change and any of the previous mentioned
parameters. This can be visualized on Figure 6.11 where the values of the rCBF
versus those parameters are shown for the severe population.
In these plots, a tendency can be seen in the representation of the flow
response versus the Mean SpO2. In compliance with the results achieved when
considering the total orthostatic challenge, this relation implies that the blood
flow response is stronger for those patients that present better oxygen saturation
values. However, the large errorbars inherent to the nature of the data and the
short range of the Mean SpO2 produce poor statistics. In fact, this trend would
disappear if we remove the two patients with oxygen saturation values lower
than 87.5. A similar thing occurs when exploring the relation with the rCBF
and the remaining parameters. For instance, in the case of the BMI or the CT90,
the trends found suggest that patients with higher BMI or CT90 values would
present worst blood flow response in contrast to the ODI4% where patients with
worst respiratory condition (higher values of ODI4%) would present better blood
flow response.
This evidence is eventually more clear when we explore the dependence of
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Figure 6.11: Exploring the rCBF at 0 to 30 versus a set of key respiratory
parameters for the Severe Group. The blue areas represents the confidence
intervals for the models whereas the pink ones cover the area ± twice the standard
deviation.
the blood flow response and the Apnoea-Hypopnoea Index even when the data
range was extended to the total population. This is illustrated in Figure 6.12
where we can see that there is no relation between these two parameters. The
first thing to consider in this case is the nature of this index in terms of the data
range. For instance, patients were recruited according to the severity of the OSA
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Figure 6.12: Exploring the rCBF versus the AHI for all the groups. The blue
areas represents the confidence intervals for the models whereas the pink ones
cover the area ± twice the standard deviation.
syndrome. In consequence, we have groups which present similar percentages of
population like for instance the Mild (34.9%) and Severe (33.7%) but they cover
different ranges of the AHI index. In the case of the Mild group, all these patients
are located in a range of 15 points whereas the Severe group is disperse in a
range of 70 points. Furthermore, the blood flow responses show high variability
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along the whole AHI range but it is particularly interesting that this variability
stands for low AHI ranges (< 15) where we would have expected that patients
will show higher CBF changes in comparision to the flow responses obtained for
patients with very high AHI (> 75).
6.3.5 Exploring The Slope
In this section I have proceeded in a similar manner but using the Slope instead,
which by definition involves the whole orthostatic challenge. For the same reasons
explained in the previous section, any patient presenting paradoxical response
in the 0◦ to 30◦ change was excluded from the models produced. The results of
these models can be check on table 6.9.
Non-OSA Mild Moderate Severe Total
AHI NA NA NA 0.183 0.449
Mean SpO2 NA NA NA 0.102 0.658
CT90 NA NA NA 0.331 0.594
ODI4% NA NA NA 0.279 0.671
BMI NA NA NA 0.651 0.86
Table 6.9: P-Values for LME with Slope as a fixed factor. NA=Not Applicable.
Again, the NA text remarks the prior discussed point of the low range of the
parameters involved, being this restriction applied to the Non-OSA, Mild and
Moderate groups. As with the rCBF exploration at the 0◦ to 30◦ change, no
relation was found between the Slope derived from the orthostatic test on the
Severe and the Total population with any of the parameters involved.
This can be visualized on Figure 6.13 where the values of the Slope versus
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those parameters are shown for the severe population.
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Figure 6.13: Exploring the Slope versus a set of key respiratory parameters for
the Severe Group. The blue areas represents the confidence intervals for the
models whereas the pink ones cover the area ± twice the standard deviation.
In these plots, similar tendencies were obtained than those when considering
the rCBF induced at the 0◦ to 30◦ change. For instance, in compliance with
previous results, there is a clear trend where the Slope present higher (negative)
values for those patients who have better oxygen saturation values. However, the
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statistics for this model are poor due to the the large errorbars and the short
range of the Mean SpO2. As before, this trend would disappear if we remove
the previously mentioned two patients with oxygen saturation values lower than
87.5. The results obtained for the BMI, ODI4% and CT90 present similar trends
than those obtained for the rCBF induced at the 0◦ to 30◦ change.
Similarly, no relation was found either between Slope and the Apnoea-Hypopnoea
Index when the data range was extended to the total population as illustrated
in Figure 6.14. As before, this model lacks of statistical significance due to the
same issues related to the AHI range. However, the rCBF variability is lower
for low AHI ranges (< 15) and surprisingly patients with very low AHI present
low Slope values which means that their global blood flow change along the
orthostatic challenge is low.
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Figure 6.14: Exploring the Slope versus the AHI for all the groups. The blue
areas represents the confidence intervals for the models whereas the pink ones
cover the area ± twice the standard deviation.
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6.4 Discussion
I have used an orthostatic challenge test to study the cerebral hemodynamics of
cohort of OSA patients (n=69) and a control group of healthy subjects (n=14).
In compliance with previous studies [33, 37, 38, 77], DCS was able to distinguish
the hemodynamical response induced by the HOB change although we were not
able to distinguish between AHI-based groups of patients.
The values obtained for blood flow response to the initial 0◦ to 30◦ change
represented in Table 6.5 are very similar to those achieved by Edlow et al.
from a cohort of healthy subjects [38]. In this regards, the Apnoea-Hypopnoea
Index has been validated to classify the severeness of the OSA syndrome and
many works relate increase cardiovascular risk in patients with AHI>30 [143].
However, the AHI classification might not be enough to find hidden impaired
cerebral autoregulation in OSA patients.
In this regards, endothelium plays an important role in the cerebral autoreg-
ulation mechanisms by regulating the resting tone of the vessels through the
release of the potent vasoactive factors such as nitric oxide [147]. In the case of
OSA patients, it was found that they present abnormal endothelium -dependent
and independent vasodilation [148,149] and increased sympathetic nerve activity
that leads to increased vasoconstriction [150–152]. This mechanism provokes
an increased of the vascular oxidative stress that alters the vascular tone regu-
lation of the brain [153]. Also, an increase of intravascular pressure induces a
vasoconstriction through a myogenic response that alters the vessel resistance
adjustments [154] and leads to alterations in the cerebral autoregulation [155].
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The paradoxical responses were a significant finding in severely injured sub-
jects [33, 77] but this study did not present a large population (4.8%). The
reasons that causes this paradoxical responses still remain nowadays unclear but
could be related to high intracranial pressure (ICP) or heart failure [156,157].
On the other hand, when looking at the mean values of rCBF and SNORM
rCBF on Tables 6.5-6.6 it was found that the control group of healthy subjects
presented some differences when comparing to the OSA patients. For instance,
they seem to easily recover the rCBF baseline values when returning from 30◦
or −8◦ to the supine positions. This is reflected on the rCBF values for those
angles (-4.4% ±2.5% and -5.6% ±4.3% respectively) and it is also in compliance
with the fact that the control group of healthy subjects is the only one where
the SNORM rCBF values at 0◦ to 30◦ and 30◦ to 0◦ are very similar in terms of
absolute value (17.3% ±2.7% versus 16.4% ±2.9%). In contrast, the rCBF values
obtained for the OSA groups when returning from 30◦ or −8◦ to the supine
positions are of 4.4% ±2.5% and 11.5% ±3.2% for the Milds, 8.1% ±3.6% and
19.1% ±4.8% for the Moderates and 7.5% ±2.5% and 16% ±3.7% for the Severes.
Similarly, we can see that the absolute value of the SNORM rCBF differs in the
OSA groups for the 0◦ to 30◦ and 30◦ to 0◦ changes. These values are of 17.5%
±1.8% and 27.9% ±3.9% for the Milds, 17.7% ±2.3% and 31.3% ±2.3% for the
Moderates and 16.2% ±2% and 29.6% ±3.6% for the Severes.
Furthermore, results obtained from a paired t-test and summarized in Ta-
ble 6.7 demonstrates that HOB changes of similar magnitude (around ±30◦)
produce different blood flow responses in absolute value in the OSA population
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when compared to the control group. These changes are higher for the OSA
groups at −30◦ and −28◦ when compared to 30◦ whereas the flow response ob-
tained for the control group is the same for all these three angles of 30◦, −30◦
and −28◦.
One possibility that could explain these results is that OSA patients might
need longer period of time than the 5 minutes they stayed on each position to
stabilize their hemodynamical response. In compliance with this result, a previous
study carried out during wakefulness show that OSA patients present impaired
compensatory response to an orthostatic challenge [10]. This impairment was
reflected in the significantly slower rate of recovery of the cerebral blood flow
velocity (CBFV) and MAP versus a control group of healthy patients.
The blood flow response was also found to be dependent on the Mean SpO2
and BMI for the total orthostatic challenge. However, this statistical finding
needs to be considered cautiously as the short range of both Mean SpO2 and
BMI variables might have weakened the strength of these models. In relation to
this point, we must also take into consideration that the sleep parameters used in
this study were measured only once and at night whilst the DCS measurements
were carried out during the day. In relation to this point, the impairment in
the cerebrovascular reactivity provoked by the apneic events during sleep is
maintained during daytime [158] although reduced when compared to early
morning measurements.
The combination of DCS and HOB seems to be a good test but it has only
been validated in studies carried out with severed injured patients [33, 37, 77].
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One possibility that could explain why OSA groups present similar blood flow
responses and therefore we cannot distinguish between them is that the test is
not sensitive enough in milder cases than severe injured patients. This sensitivity
could be improved by using a stronger and faster body positioning challenge (full
reversal). In this regards, for technical reasons the bed manipulation performed
in this study was done manually and slowly (around 15 second for the 0◦ to 30◦
change). Another alternative is to use a leg cuff release protocol [36]. However, the
strong dilation in the artery endothelium induced by this protocol can increase
the coronary risk factors [159]. Also, changes in the cerebral blood flow could
be induced by acetazolamide [160] which is mildly invasive although its use can
produce side effects [161] such as headache, nausea or general malaise.
As an overall, the blood flow responses obtained in this study suggest that
through a carefully conducted study on recovery dynamics we might be able
to reveal better discriminatory capabilities. In any case, the method used in
this study appears suitable given the large population studied, yet the correct
protocol in a future study is to be defined.
6.5 Conclusion
I have studied the cerebral hemodynamics of 83 patients in response to an
orthostatic challenge. From the results obtained we were able to distinguish the
hemodynamical response induced by the HOB change although were not able to
differentiate between AHI-based groups of patients. In order to succeed at this
levels, more patients per group would be needed to recruit for a future study.
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This study also shows that healthy subjects seem to have higher capacity to
recover to the CBF values when returning to the supine position in contrast
to those classified as OSA patients. In this regards, I have explored possible
correlations between the blood flow response to the orthostatic challenge versus
a set of key respiratory parameters and particularly the Apnoea-Hypopnoea
Index used to classified OSA patients according to the severity of this syndrome.
The lack of relations found suggest that this index might not be appropriated
to identify impaired cerebral autoregulation. This fact suggest that DCS could
play a role as a diagnose tool for evaluating the CVR future clinical trials.
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Table 6.10: List of acronyms
AIS Acute ischemic stroke
AHI Apnoea-Hypopnoea Index
BMI Body mass index
CA Cerebral autoregulation
CPAP Continuous positive air pressure
CT90 % of time during the study where the SpO2 was lower than 90%
CVR Cerebrovascular reactivity
ODI4% # of times/hour where the SpO2 decreases 4% due to an apnoea
OSA Obstructive sleep apnoea
SpO2 Arterial oxygen saturation
PSG Polysomnography
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7
Conclusions
Several biomedical applications based on diffuse optical techniques have been
described along this manuscript. In all these scenarios I had to face different
challenges such as developing new optical probes through a fully non-invasive
approach, engineering solutions to secure the correct probe positioning over
the rat scalp and human heads or developing new protocols to secure the op-
tical measurement in small rat brain areas. In these regards, I would like to
thank my collaborators at the Stroke and Sleep units of Hospital de la Santa
Creu i Sant Pau and the Department of Brain Ischemia and Neurodegeneration,
Institute for Biomedical Research (IIBB), Spanish Research Council (CSIC), In-
stitut d’Investigacions Biome`diques August Pi i Sunyer (IDIBAPS) from whom
I learned a lot about animal and human physiology and from where I got con-
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tinuous feedback and support along these years.
The results obtained in this thesis reflect the great potential of this technology
to obtain information about the hemodynamics of humans and rodents through
a fully non-invasive manner. This fact plus some extra features like for instance
its low cost and/or portability makes it very attractive in biological and medical
studies.
Also, this technology has been capable to be used simultaneously with medical
sensors (such as polysomnography and/or transcraneal doppler) and has also
the potential to be used simultaneously with MRI. This fact opens the door to
proceed with multi-disciplinary experiments in future studies.
As a summary, here they are the main conclusions of this Thesis.
Non-invasive monitoring of functional activation in rat brain
with DCS
In this study, I have described the performance of both an implanted and surface
probes which allow to measure the functional activation in rats in a fully non
invasive manner. The main advantage from the implantable probe comes from
the relatively low signal-to-noise ratio caused by the absence of scalp and the
accuracy in tracking the right regions of interest. Also, it allows to proceed with
optical and MRI measurements simultaneously.
The surface probe eliminates the minimal surgery needed for the use of the
implantable probe and the risk of infections derived from it, allowing to proceed
with longer longitudinal studies (a year duration or longer eventually). This fact
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opens the possibility of studying chronic phases of neurodegenerative pathologies
and possible recovery therapies.
Monitoring cerebral hemodynamics during early hours af-
ter stroke
In this chapter, I have studied the blood flow response to an orthostatic challenge
during the early hours after the stroke onset. The results obtained have revealed
to provide promising information to predict the outcome of ischemic stroke
patients according to the functional modified Rankin Scale.
This finding could be of great use to improve the medical diagnose and might
open the gate to ad hoc treatments by simply using a head-of-bed challenge in
the early hours after the stroke onset.
Once more, diffuse correlation spectroscopy has proved its capability to iden-
tify paradoxical responders and therefore to provide neurologist with relevant
information about the cerebral hemodynamics of ischemic stroke patients.
Cerebral hemodynamics of Obstructive Sleep Apnoea pa-
tients in response to orthostatic challenge
In this last chapter, I have monitored the cerebral hemodynamics of a large
cohort (n=69) of Obstructive Sleep Apnoea (OSA) patients and compared their
blood flow responses to an orthostatic challenge with a control group of healthy
subjects (n=14). The hemodynamical responses induced by the head-of-bed
(HOB) challenge were successfully measured by DCS although we were not able
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to distinguish between groups of patients clustered according to the Apnoea-
Hypopnoea Index (AHI).
The results obtained also show that healthy subjects seem to have a higher
capacity to recover to initial cerebral blood flow values when altering the HOB
from supine to 30 and return back to supine position. The fact that the blood
flow response to the orthostatic challenge is not dependent on the AHI suggests
that this index might not be appropriated to identify impaired cerebrovascular
reactivity or cerebral autoregulation.
As an overall, the blood flow responses to an orthostatic challenge suggest
that through a carefully conducted study on recovery dynamics we might be
able to reveal better discriminatory capabilities and therefore to produce more
sophisticated models about cerebral hemodynamics and respiratory parameters.
In relation to this point, DCS could play a role as a diagnose tool for evaluating
the cerebrovascular reactivity in future clinical trials.
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